幽门螺杆菌空泡毒素与线粒体腺嘌呤核苷酸转移酶相互作用的研究
|
摘要
幽门螺杆菌(Helicopter pylori,Hp)是人体内最常见的病原微生物之一,其感染率约占世界人口的50%。目前我国约有7亿人已感染Hp,未感染人群也普遍易感。流行病学研究提示Hp与胃癌的发生关系密切,世界卫生组织(WHO)已把Hp列为胃癌的首要致病因子。Hp感染引起的胃上皮细胞凋亡异常在胃癌的发生发展中起主要作用,但是其具体机制尚不清楚。Hp空泡细胞毒素(Vacuolating cytotoxin,VacA)与Hp产生的其它已知细菌毒素无明显的同源性,因其可致真核上皮细胞发生空泡变性而得名,是目前倍受关注的细胞毒力因子之一。胃癌患者所感染的Hp大多含有VacA,推测其在胃癌发生过程中可能起着较为重要的作用。VacA作为Hp的主要毒力因子,诱导上皮细胞凋亡是引发细胞癌变的关键分子,VacA诱导凋亡的作用与致空泡的作用虽有关联但不互为因果,但均与其膜通道活性改变有关。进一步研究发现VacA进入上皮细胞,能够靶向线粒体,引起线粒体膜通透性发生转换(mitochondrial permeability transition,MPT),造成线粒体跨膜电位降低、细胞色素c释放、活化凋亡相关因子等一系列变化,诱导细胞发生凋亡, VacA导致MPT的机理尚不明确。
腺嘌呤核苷酸转移酶(adenine nucleotide translocase,ANT)是线粒体内膜上含量最丰富的蛋白。它是将细胞的产能和耗能过程耦联起来的主要载体,也是组成线粒体膜通透性转换孔(mitochondrial permeability transition pore,MPTP,或简称PT孔)的关键组分,参与调节线粒体膜通透性转换孔的开放,与细胞凋亡紧密相关。线粒体凋亡途径是细胞的内源性凋亡途径,线粒体凋亡的发生最终都归结于MPT,而MPT的发生又是由于PT孔的开放所致。PT孔的分子构成尚不完全清楚,但目前已明确ANT是其位于线粒体内膜的关键蛋白,它在线粒体内、外膜的交接点处可形成“非特异性孔道”,通过它的开放、关闭以及与一些凋亡调控因子(如Bax/bcl-2家族)的互动,参与组织细胞凋亡的调控。VacA可以迅速转运至线粒体内膜,其导致的线粒体内膜通透性转换明显早于外膜通透性转换。其它配体或蛋白质可与ANT发生相互作用改变其构象来控制PT孔的开放与关闭,通过调节膜通透性的改变来达到调控细胞凋亡的目的,ANT在MPT中处于核心地位。研究VacA与ANT的相互作用关系,将有助于进一步明确VacA致MPT的机理。本研究通过酵母双杂交和免疫共沉淀来探索VacA与ANT的相互作用关系,为阐明Hp通过线粒体凋亡途径诱发胃癌的分子机制提供科学依据。
1.酵母双杂交诱饵质粒的构建及鉴定提取幽门螺杆菌标准毒株NCTC11637基因组DNA,PCR扩增VacA片段,并将其克隆入pGBKT7载体构建pGBKT7-VacA诱饵质粒。通过酶切和测序鉴定诱饵质粒构建成功后,将诱饵质粒转化宿主酵母菌AH109后,提取酵母总蛋白,Western-Blot分析重组蛋白的活性。同时分别检测了诱饵质粒的毒性、渗漏和自激活活性。结果显示构建的诱饵质粒对酵母菌无毒性、无渗漏也未表现自激活活性。
2.酵母双杂交猎物质粒的构建及鉴定RT-PCR扩增ANT各异构体——ANT1、ANT2、ANT3基因,并分别将它们克隆入pGADT7载体构建pGADT7-ANT1、pGADT7-ANT2、pGADT7-ANT3猎物质粒,进行酶切和测序鉴定。各猎物质粒分别转化宿主酵母菌Y187后,提取酵母总蛋白,Western-Blot分析各重组蛋白的活性。一系列活性和毒性检测结果表明全部质粒均具有天然活性、对宿主未表现毒性,并且无渗漏和自激活活性。
3.酵母双杂交试验将转化了诱饵质粒pGBKT7-VacA的酵母菌AH109分别与转化了猎物质粒pGADT7-ANT1、pGADT7-ANT2、pGADT7-ANT3的酵母菌Y187两两配对交配培养,富集交配后的合子铺不同严谨程度营养缺陷培养基,X-α-Gal检测报告基因的激活,结果未检测到报告基因的转录,表明VacA与ANT在酵母双杂交系统内未发生相互作用。
4.VacA免疫共沉淀载体的构建及鉴定以pGBKT-VacA质粒DNA为模板,PCR扩增得到VacA片段并将其克隆入pCMV-Myc载体中构建pCMV-Myc-VacA表达质粒。将构建好的质粒采用脂质体法瞬时转染AGS细胞,Western Blot检测重组质粒在AGS细胞内的表达,结果表明重组蛋白得到正确表达。
5.ANT各异构体免疫共沉淀载体的构建及鉴定分别以pGADT7-ANT1、pGADT7-ANT2、pGADT7-ANT3质粒DNA为模板,PCR扩增ANT1、ANT2、ANT3基因片段,并将其分别克隆入pCMV-HA载体中构建pCMV-HA-ANT1、pCMV-HA-ANT2、pCMV-HA-ANT3融合表达质粒。将构建好的各质粒采用脂质体法分别瞬时转染AGS细胞,Western Blot检测各重组质粒在AGS细胞内的表达,结果表明各重组蛋白均得到正确表达。
6 .免疫共沉淀试验将pCMV-Myc-VacA载体分别与pCMV-HA-ANT1、pCMV-HA-ANT2、pCMV-HA-ANT3载体配比瞬时共转染AGS细胞,提取细胞总蛋白进行免疫共沉淀试验,分别用VacA抗体沉淀ANT(ANT1、ANT2、ANT3)和ANT抗体沉淀VacA,验证二者在细胞内的蛋白相互作用。结果表明VacA与ANT之间不能发生免疫共沉淀反应。
Helicobacter pylori (Hp) is most common pathogenic bacteria, which infection presently affects approximately one-half of the world’s population and seven hundred million people in our country, and the health people are very susceptible to it.Hp leads to chronic gastritis, the most frequent chronic inflammation worldwide.It is also aetiologically associated with gastric and duodenal ulcer, mucosa associated lymphoid tissue (MALT) gastric lymphoma and gastric cancer (GC). Since then, data from several epidemiological, interventional and experimental studies have been gathered, confirming the causal link between Hp and GC. Ecological studies mostly confirm the geographical association between the prevalence of Hp and prevalence of GC.It has been evident for over 20 years that Hp is involved in the development of gastric cancer; in 1994, the WHO concluded that Hp is a definite or class I carcinogen in humans.Prospective studies reveal that the risk for development of gastric cancer is much greater in Hp-infected populations than in uninfected populations. The development of GC is a multistep process that is multi-factorial. The most important risk factor is the infection with Hp. The pathogenesis of GC includes a sequence of events that begins with Hp-induced chronic superficial gastritis, progressing towards atrophic gastritis, intestinal metaplasia, dysplasia and eventually GC. The“driving force”of GC is a chronic gastric inflammation, whose intensity and localization depending on the bacteria infection. The mechanisms by which chronic inflammation lead to epithelial and pre-cancerous lesions include induction of oxidative stress, perturbation of the epithelial cells proliferation/apoptosis ratio, and cytokine secretion. The end-stage of the multistep process of GC corresponds to accumulation of molecular alterations involving either the suppressor pathway (defect in tumour suppressor genes) or the mutator pathway (defect in DNA mismatch repair genes).The abnormality of gastric epithelial cells proliferation or apotosis is playing the most important roles in development to GC which caused by Hp infections.While the mechanisms of Hp associated cells apotosis are still relatively poorly defined, the elucidation may provide opportunities to develop effective strategies for GC prevention and therapy. Chronic gastritis induced by Hp is a strong risk factor for the development of distal gastric adenocarcinoma. A specific host response to Hp that may contribute to gastric carcinogenesis is epithelial cell apoptosis. VacA is one of the most important virulence factors of Hp that is extracellular and causes damage to the gastric epithelial layer as a result of vacuolation of late endosomal and lysosomal compartments of these cells. VacA-producing Hp strains are found in the vast majority of patients with GC, powerful evidences were discovered that it has important contributions to the development of GC.VacA has also been shown to be directly involved in mucosal damage in GC. This damage might be attributed to the vacuolating as well as to the apoptosis-inducing activity of VacA. Therefore, elucidation of VacA as an apoptosis-inducing factor might offer a better understanding of the pathogenesis of Hp-related diseases such as GC. The VacA is a unique proteinous cytotoxin producted by Hp that showed no striking primary sequence homology with other known bacterial toxins.The cytotoxin is an important factor in the pathogenesis of Hp, which induces vacuolating of epithelial cells and plays an important role in gastric epithelial apotosis. Hp induces cell death by apoptosis. However, the mechanism of apoptosis-inducing factor is still unknown.The virulence factor VacA is a potential candidate.Cellular vacuolation and mitochondrial cytochrome c release are independent outcomes of VacA cytotoxin activity that are each dependent on membrane channel formation. Hp VacA which causes vacuolation of gastric epithelial cells and other types of cultured cells,is known to enter mammalian cells,localizes to the mitochondrial, induced an inactivation of energy metabolism followed by mitochondrial damage,leading to impairment of the cell cycle in gastric epithelial cells,and modulates mitochondrial membrane permeability resulting in reduction of mitochondrial transmembrane potential by a mechanism dependent on toxin channel activity ultimately resulting in cytochrome c release,stimulate apoptosis via a mitochondrial- dependent pathway.
Mitochondrial apoptosis pathway is endogenous cell death pathway. Mitochondria are important organelles for energy production, Ca2+ homeostasis, and cell death. In recent years, the role of the mitochondria in apoptotic has received much attention.In apoptotic, an increase of mitochondrial membrane permeability is considered to be one of the key events, although the detailed mechanism remains to be elucidated. The mitochondrial membrane permeability transition (MPT) is increase in the permeability of the mitochondrialmembrane that leads to loss ofΔψm,mitochondrial swelling, and rupture of the outer mitochondrial membrane.The MPT is thought to occur after the opening of a channel, which is termed the permeability transition pore (MPTP) and core constitution consists of the voltage-dependent anion channel (VDAC) in the outer mitochondrial membrane (OM), the adenine nucleotide translocator (ANT) in the innermembrane (IM) and cyclophilin D (Cyp D) in the mitochondrial matix. Mitochondrial membrane permeabilization can be a rate limiting step of apoptotic as well as necrotic cell death.Permeabilization of the OM and/or IM is, at least in part, mediated by the permeability transition pore complex (PTPC). The PTPC is formed in the IM/OM contact site and contains the two most abundant IM and OM proteins, ANT and VDAC,the matrix protein cyclophilin D,which can interact with ANT, as well as apoptosis-regulatory proteins from the Bax/Bcl-2 family.The MPTP is a non-specific pore, permeant to any molecule of < 1.5 kDa, that opens in the inner mitochondrial membrane under conditions of elevated matrix [Ca2+], especially when this is accompanied by oxidative stress and depleted adenine nucleotides. Opening of the MPTP causes massive swelling of mitochondria, rupture of the outer membrane and release of intermembrane components that induce apoptosis. In addition mitochondria become depolarised causing inhibition of oxidative phosphorylation and stimulation of ATP hydrolysis. Thus, in many cases, the PT appears to be the mastermind that orchestrates apoptosis. Alteration of mitochondrial membrane permeability is a central mechanism leading invariably to cell death. Indeed, extended PTPC opening is sufficient to trigger an increase in mitochondrial membrane permeability and apoptosis. Among the various PTPC components, the ANT appears to act as a bi-functional protein which, on the one hand, contributes to a crucial step of aerobic energy metabolism, the ADP/ATP translocation, and on the other hand, can be converted into a pro-apoptotic pore under the control of onco- and anti-oncoproteins from the Bax/Bcl-2 family.Additionally,VacA likes as an A-B type cytotoxin, binds to cells primarily via amino acid sequences in its B subunit—p58,and it is necessary for enzymatic activity of A subunit—p37.Meanwhile, research indicated that the residues are situated in 418 aa to 799 aa of p58 fragment madiate the development of gastric diseases through cell cycle arrest in the G1 phase and induction of apoptosis is associated with up-regulation of apoptosis related factors.To summarized,we speculated that VacA and ANT formation the complex, then changed the channel activity of mitochondrial membrane, leaded to MPT eventually. In present study, apply to Yeast Two-Hybrid and Co-immunoprecipitation to explored the hypothesis that the protein interaction between VacA and ANT isoforms,VacA and ANT formation the complex induced the mitochondria membrane transition.Expected to clarify the mechanism of VacA induce cell apotosis,for the purpose of supply new clues of molecular mechanism of Hp infections evocated GC by mitochondrial apoptosis pathway.
1. Construction and identification of the“bait”plasmid of Yeast Two-Hybrid: Extracted the genome DNA from Helicobacter pylori standard strain NCTC11637, the gene encoding Vacuolating cytotoxin partial sequences was amplified by PCR and then cloned into pGBKT7 to construct the pGBKT7-VacA bait plasmid. Insert-contained plasmid was confirmed by restriction endonuclease analysis and DNA sequencing. And then the bait plasmid were transformed into the host S.cerevisiae AH109,the results of recombinant protein detection by Western Blot indicated that the protein translated correctly; meanwhile, the bait plasmid also have no cytotoxin, no leakage and no auto-activated activities. This work was important for the further verification of the protein interaction with VacA.
2. Construction and identification of the“prey”plasmids of Yeast Two-Hybrid: Each open reading frame (ORF) of the ANT isoforms were amplified by RT-PCR and then cloned into the pGADT7 respectively, to construct the prey plasmids pGADT7-ANT1, pGADT7-ANT2 and pGADT7-ANT3. After proved by restrict endonuclease digesting and DNA sequencing, the prey plasmids were transformed into S.cerevisiae Y187 separately, then the expression of the prey proteins were analyzed by Western Blot severally. A series of cytotoxin and activity performances of the prey plasmids were detected, the results indicated that all of these plasmids have natural activity and have no toxincity, leakage and auto-activated activities.These achievements provided the foundation for inspect the combination partner of ANT in the Yeast Two-Hybrid System.
3. Yeast Two-Hybrid: Transform AH109 with pGBKT7-VaA and transform Y187 with pGADT7-ANT1 or pGADT7-ANT2 or pGADT7-ANT3.The two types of cells were co-cultured in liquid SD/-Trp/-Leu medium.After mating,the plasmids were introduced into the same host cells,centrifuged cells and plate culture on Low-stringency,Medium-stringency, High-stringency plates sequentially.Verify the protein interaction afterβ-galactosidase assays. None of all experimental groups activated the reporter genes transcription, there were means that have no protein interactions between each other in our test system.
4. Construction and Identification of the pCMV-Myc-VacA expression vector: The pGBKT7-VacA plasmid DNA as template, amplified VacA fragment by PCR, and cloned into plasmid pCMV-Myc. After identificated by restriction endonuclease digested and then transient transfected into AGS cells by using lipofectamine 2000.Detected the recombinant protein by Western Blot analysis. The results demonstrated that the recombinant protein translated correctly.This study offers the basis for further research of co-immunoprecipitation protein of VacA.
5. Construction and Identification of the pCMV-HA-ANT expression vectores: Set up the Yeast Two-hybrid prey plasmids as the templates.Amplified the ANT fragments by PCR respectively.And then cloned into the HA-tag expression vector pCMV-HA. Identificated by restriction endonuclease digested and transient transfected into AGS cells by using lipofectamine 2000 separately. All the expression plasmids were proofed that they were translated exactly by Western Blot assays.
6. Co-Immunoprecipitation: The Myc-tag plasmid pCMV-Myc-VacA and the HA-tag plasmids pCMV-HA-ANT1 or pCMV-HA-ANT2, pCMV-HA-ANT3 were co-transfected into AGS cells with optimal combination. The cells were homogenized in lysis buffer, and then added the first primary antibody into the supernatant, after 4 hours incubation, added the Protein A beads in it and incubated overnight at low velocity rotary conditions. After that, the Protein A beads were pelleted, then Western Blot were performed by using another primary antibody, to verified the protein interactions at physiological circumstance.Detected the protein interactions by Co-immunoprecipitation approach. No matter how VacA immunoprec- ipitation ANT or ANT immunoprecipitation VacA, there were no phenomenons had been detected that revealed where the co-immunoprecipitation happened between each other.
腺嘌呤核苷酸转移酶(adenine nucleotide translocase,ANT)是线粒体内膜上含量最丰富的蛋白。它是将细胞的产能和耗能过程耦联起来的主要载体,也是组成线粒体膜通透性转换孔(mitochondrial permeability transition pore,MPTP,或简称PT孔)的关键组分,参与调节线粒体膜通透性转换孔的开放,与细胞凋亡紧密相关。线粒体凋亡途径是细胞的内源性凋亡途径,线粒体凋亡的发生最终都归结于MPT,而MPT的发生又是由于PT孔的开放所致。PT孔的分子构成尚不完全清楚,但目前已明确ANT是其位于线粒体内膜的关键蛋白,它在线粒体内、外膜的交接点处可形成“非特异性孔道”,通过它的开放、关闭以及与一些凋亡调控因子(如Bax/bcl-2家族)的互动,参与组织细胞凋亡的调控。VacA可以迅速转运至线粒体内膜,其导致的线粒体内膜通透性转换明显早于外膜通透性转换。其它配体或蛋白质可与ANT发生相互作用改变其构象来控制PT孔的开放与关闭,通过调节膜通透性的改变来达到调控细胞凋亡的目的,ANT在MPT中处于核心地位。研究VacA与ANT的相互作用关系,将有助于进一步明确VacA致MPT的机理。本研究通过酵母双杂交和免疫共沉淀来探索VacA与ANT的相互作用关系,为阐明Hp通过线粒体凋亡途径诱发胃癌的分子机制提供科学依据。
1.酵母双杂交诱饵质粒的构建及鉴定提取幽门螺杆菌标准毒株NCTC11637基因组DNA,PCR扩增VacA片段,并将其克隆入pGBKT7载体构建pGBKT7-VacA诱饵质粒。通过酶切和测序鉴定诱饵质粒构建成功后,将诱饵质粒转化宿主酵母菌AH109后,提取酵母总蛋白,Western-Blot分析重组蛋白的活性。同时分别检测了诱饵质粒的毒性、渗漏和自激活活性。结果显示构建的诱饵质粒对酵母菌无毒性、无渗漏也未表现自激活活性。
2.酵母双杂交猎物质粒的构建及鉴定RT-PCR扩增ANT各异构体——ANT1、ANT2、ANT3基因,并分别将它们克隆入pGADT7载体构建pGADT7-ANT1、pGADT7-ANT2、pGADT7-ANT3猎物质粒,进行酶切和测序鉴定。各猎物质粒分别转化宿主酵母菌Y187后,提取酵母总蛋白,Western-Blot分析各重组蛋白的活性。一系列活性和毒性检测结果表明全部质粒均具有天然活性、对宿主未表现毒性,并且无渗漏和自激活活性。
3.酵母双杂交试验将转化了诱饵质粒pGBKT7-VacA的酵母菌AH109分别与转化了猎物质粒pGADT7-ANT1、pGADT7-ANT2、pGADT7-ANT3的酵母菌Y187两两配对交配培养,富集交配后的合子铺不同严谨程度营养缺陷培养基,X-α-Gal检测报告基因的激活,结果未检测到报告基因的转录,表明VacA与ANT在酵母双杂交系统内未发生相互作用。
4.VacA免疫共沉淀载体的构建及鉴定以pGBKT-VacA质粒DNA为模板,PCR扩增得到VacA片段并将其克隆入pCMV-Myc载体中构建pCMV-Myc-VacA表达质粒。将构建好的质粒采用脂质体法瞬时转染AGS细胞,Western Blot检测重组质粒在AGS细胞内的表达,结果表明重组蛋白得到正确表达。
5.ANT各异构体免疫共沉淀载体的构建及鉴定分别以pGADT7-ANT1、pGADT7-ANT2、pGADT7-ANT3质粒DNA为模板,PCR扩增ANT1、ANT2、ANT3基因片段,并将其分别克隆入pCMV-HA载体中构建pCMV-HA-ANT1、pCMV-HA-ANT2、pCMV-HA-ANT3融合表达质粒。将构建好的各质粒采用脂质体法分别瞬时转染AGS细胞,Western Blot检测各重组质粒在AGS细胞内的表达,结果表明各重组蛋白均得到正确表达。
6 .免疫共沉淀试验将pCMV-Myc-VacA载体分别与pCMV-HA-ANT1、pCMV-HA-ANT2、pCMV-HA-ANT3载体配比瞬时共转染AGS细胞,提取细胞总蛋白进行免疫共沉淀试验,分别用VacA抗体沉淀ANT(ANT1、ANT2、ANT3)和ANT抗体沉淀VacA,验证二者在细胞内的蛋白相互作用。结果表明VacA与ANT之间不能发生免疫共沉淀反应。
Helicobacter pylori (Hp) is most common pathogenic bacteria, which infection presently affects approximately one-half of the world’s population and seven hundred million people in our country, and the health people are very susceptible to it.Hp leads to chronic gastritis, the most frequent chronic inflammation worldwide.It is also aetiologically associated with gastric and duodenal ulcer, mucosa associated lymphoid tissue (MALT) gastric lymphoma and gastric cancer (GC). Since then, data from several epidemiological, interventional and experimental studies have been gathered, confirming the causal link between Hp and GC. Ecological studies mostly confirm the geographical association between the prevalence of Hp and prevalence of GC.It has been evident for over 20 years that Hp is involved in the development of gastric cancer; in 1994, the WHO concluded that Hp is a definite or class I carcinogen in humans.Prospective studies reveal that the risk for development of gastric cancer is much greater in Hp-infected populations than in uninfected populations. The development of GC is a multistep process that is multi-factorial. The most important risk factor is the infection with Hp. The pathogenesis of GC includes a sequence of events that begins with Hp-induced chronic superficial gastritis, progressing towards atrophic gastritis, intestinal metaplasia, dysplasia and eventually GC. The“driving force”of GC is a chronic gastric inflammation, whose intensity and localization depending on the bacteria infection. The mechanisms by which chronic inflammation lead to epithelial and pre-cancerous lesions include induction of oxidative stress, perturbation of the epithelial cells proliferation/apoptosis ratio, and cytokine secretion. The end-stage of the multistep process of GC corresponds to accumulation of molecular alterations involving either the suppressor pathway (defect in tumour suppressor genes) or the mutator pathway (defect in DNA mismatch repair genes).The abnormality of gastric epithelial cells proliferation or apotosis is playing the most important roles in development to GC which caused by Hp infections.While the mechanisms of Hp associated cells apotosis are still relatively poorly defined, the elucidation may provide opportunities to develop effective strategies for GC prevention and therapy. Chronic gastritis induced by Hp is a strong risk factor for the development of distal gastric adenocarcinoma. A specific host response to Hp that may contribute to gastric carcinogenesis is epithelial cell apoptosis. VacA is one of the most important virulence factors of Hp that is extracellular and causes damage to the gastric epithelial layer as a result of vacuolation of late endosomal and lysosomal compartments of these cells. VacA-producing Hp strains are found in the vast majority of patients with GC, powerful evidences were discovered that it has important contributions to the development of GC.VacA has also been shown to be directly involved in mucosal damage in GC. This damage might be attributed to the vacuolating as well as to the apoptosis-inducing activity of VacA. Therefore, elucidation of VacA as an apoptosis-inducing factor might offer a better understanding of the pathogenesis of Hp-related diseases such as GC. The VacA is a unique proteinous cytotoxin producted by Hp that showed no striking primary sequence homology with other known bacterial toxins.The cytotoxin is an important factor in the pathogenesis of Hp, which induces vacuolating of epithelial cells and plays an important role in gastric epithelial apotosis. Hp induces cell death by apoptosis. However, the mechanism of apoptosis-inducing factor is still unknown.The virulence factor VacA is a potential candidate.Cellular vacuolation and mitochondrial cytochrome c release are independent outcomes of VacA cytotoxin activity that are each dependent on membrane channel formation. Hp VacA which causes vacuolation of gastric epithelial cells and other types of cultured cells,is known to enter mammalian cells,localizes to the mitochondrial, induced an inactivation of energy metabolism followed by mitochondrial damage,leading to impairment of the cell cycle in gastric epithelial cells,and modulates mitochondrial membrane permeability resulting in reduction of mitochondrial transmembrane potential by a mechanism dependent on toxin channel activity ultimately resulting in cytochrome c release,stimulate apoptosis via a mitochondrial- dependent pathway.
Mitochondrial apoptosis pathway is endogenous cell death pathway. Mitochondria are important organelles for energy production, Ca2+ homeostasis, and cell death. In recent years, the role of the mitochondria in apoptotic has received much attention.In apoptotic, an increase of mitochondrial membrane permeability is considered to be one of the key events, although the detailed mechanism remains to be elucidated. The mitochondrial membrane permeability transition (MPT) is increase in the permeability of the mitochondrialmembrane that leads to loss ofΔψm,mitochondrial swelling, and rupture of the outer mitochondrial membrane.The MPT is thought to occur after the opening of a channel, which is termed the permeability transition pore (MPTP) and core constitution consists of the voltage-dependent anion channel (VDAC) in the outer mitochondrial membrane (OM), the adenine nucleotide translocator (ANT) in the innermembrane (IM) and cyclophilin D (Cyp D) in the mitochondrial matix. Mitochondrial membrane permeabilization can be a rate limiting step of apoptotic as well as necrotic cell death.Permeabilization of the OM and/or IM is, at least in part, mediated by the permeability transition pore complex (PTPC). The PTPC is formed in the IM/OM contact site and contains the two most abundant IM and OM proteins, ANT and VDAC,the matrix protein cyclophilin D,which can interact with ANT, as well as apoptosis-regulatory proteins from the Bax/Bcl-2 family.The MPTP is a non-specific pore, permeant to any molecule of < 1.5 kDa, that opens in the inner mitochondrial membrane under conditions of elevated matrix [Ca2+], especially when this is accompanied by oxidative stress and depleted adenine nucleotides. Opening of the MPTP causes massive swelling of mitochondria, rupture of the outer membrane and release of intermembrane components that induce apoptosis. In addition mitochondria become depolarised causing inhibition of oxidative phosphorylation and stimulation of ATP hydrolysis. Thus, in many cases, the PT appears to be the mastermind that orchestrates apoptosis. Alteration of mitochondrial membrane permeability is a central mechanism leading invariably to cell death. Indeed, extended PTPC opening is sufficient to trigger an increase in mitochondrial membrane permeability and apoptosis. Among the various PTPC components, the ANT appears to act as a bi-functional protein which, on the one hand, contributes to a crucial step of aerobic energy metabolism, the ADP/ATP translocation, and on the other hand, can be converted into a pro-apoptotic pore under the control of onco- and anti-oncoproteins from the Bax/Bcl-2 family.Additionally,VacA likes as an A-B type cytotoxin, binds to cells primarily via amino acid sequences in its B subunit—p58,and it is necessary for enzymatic activity of A subunit—p37.Meanwhile, research indicated that the residues are situated in 418 aa to 799 aa of p58 fragment madiate the development of gastric diseases through cell cycle arrest in the G1 phase and induction of apoptosis is associated with up-regulation of apoptosis related factors.To summarized,we speculated that VacA and ANT formation the complex, then changed the channel activity of mitochondrial membrane, leaded to MPT eventually. In present study, apply to Yeast Two-Hybrid and Co-immunoprecipitation to explored the hypothesis that the protein interaction between VacA and ANT isoforms,VacA and ANT formation the complex induced the mitochondria membrane transition.Expected to clarify the mechanism of VacA induce cell apotosis,for the purpose of supply new clues of molecular mechanism of Hp infections evocated GC by mitochondrial apoptosis pathway.
1. Construction and identification of the“bait”plasmid of Yeast Two-Hybrid: Extracted the genome DNA from Helicobacter pylori standard strain NCTC11637, the gene encoding Vacuolating cytotoxin partial sequences was amplified by PCR and then cloned into pGBKT7 to construct the pGBKT7-VacA bait plasmid. Insert-contained plasmid was confirmed by restriction endonuclease analysis and DNA sequencing. And then the bait plasmid were transformed into the host S.cerevisiae AH109,the results of recombinant protein detection by Western Blot indicated that the protein translated correctly; meanwhile, the bait plasmid also have no cytotoxin, no leakage and no auto-activated activities. This work was important for the further verification of the protein interaction with VacA.
2. Construction and identification of the“prey”plasmids of Yeast Two-Hybrid: Each open reading frame (ORF) of the ANT isoforms were amplified by RT-PCR and then cloned into the pGADT7 respectively, to construct the prey plasmids pGADT7-ANT1, pGADT7-ANT2 and pGADT7-ANT3. After proved by restrict endonuclease digesting and DNA sequencing, the prey plasmids were transformed into S.cerevisiae Y187 separately, then the expression of the prey proteins were analyzed by Western Blot severally. A series of cytotoxin and activity performances of the prey plasmids were detected, the results indicated that all of these plasmids have natural activity and have no toxincity, leakage and auto-activated activities.These achievements provided the foundation for inspect the combination partner of ANT in the Yeast Two-Hybrid System.
3. Yeast Two-Hybrid: Transform AH109 with pGBKT7-VaA and transform Y187 with pGADT7-ANT1 or pGADT7-ANT2 or pGADT7-ANT3.The two types of cells were co-cultured in liquid SD/-Trp/-Leu medium.After mating,the plasmids were introduced into the same host cells,centrifuged cells and plate culture on Low-stringency,Medium-stringency, High-stringency plates sequentially.Verify the protein interaction afterβ-galactosidase assays. None of all experimental groups activated the reporter genes transcription, there were means that have no protein interactions between each other in our test system.
4. Construction and Identification of the pCMV-Myc-VacA expression vector: The pGBKT7-VacA plasmid DNA as template, amplified VacA fragment by PCR, and cloned into plasmid pCMV-Myc. After identificated by restriction endonuclease digested and then transient transfected into AGS cells by using lipofectamine 2000.Detected the recombinant protein by Western Blot analysis. The results demonstrated that the recombinant protein translated correctly.This study offers the basis for further research of co-immunoprecipitation protein of VacA.
5. Construction and Identification of the pCMV-HA-ANT expression vectores: Set up the Yeast Two-hybrid prey plasmids as the templates.Amplified the ANT fragments by PCR respectively.And then cloned into the HA-tag expression vector pCMV-HA. Identificated by restriction endonuclease digested and transient transfected into AGS cells by using lipofectamine 2000 separately. All the expression plasmids were proofed that they were translated exactly by Western Blot assays.
6. Co-Immunoprecipitation: The Myc-tag plasmid pCMV-Myc-VacA and the HA-tag plasmids pCMV-HA-ANT1 or pCMV-HA-ANT2, pCMV-HA-ANT3 were co-transfected into AGS cells with optimal combination. The cells were homogenized in lysis buffer, and then added the first primary antibody into the supernatant, after 4 hours incubation, added the Protein A beads in it and incubated overnight at low velocity rotary conditions. After that, the Protein A beads were pelleted, then Western Blot were performed by using another primary antibody, to verified the protein interactions at physiological circumstance.Detected the protein interactions by Co-immunoprecipitation approach. No matter how VacA immunoprec- ipitation ANT or ANT immunoprecipitation VacA, there were no phenomenons had been detected that revealed where the co-immunoprecipitation happened between each other.
引文
蔡政杰. 2009.幽门螺杆菌感染与胃癌发病的相关性研究.吉林医学, 30(1):88~89
杜佳,邓华瑜. 2009.线粒体在细胞凋亡中的介导作用.医学教育探索, 8(3):345~348
郭颖燕,方平楚. 2003.幽门螺杆菌的vacA基因亚型及其致病性.宁夏医学杂志, 25(7):446~447
候鹏. 1999.上海人幽门螺杆菌基因表型与相关胃肠疾病.中华内科杂志, 38(11):38
胡伏莲. 2006.幽门螺杆菌感染诊疗指南.北京:人民卫生出版社,10~19
黄宜娥,姜志胜. 2008.线粒体通透性转换孔在缺血后处理中的作用和机制.生命的化学, 28(5):637~640
梁钧,袁志明,梁布锋. 2002.幽门螺杆菌基因组研究.生物化学与生物物理进展, 29(1):39~41
林妙端,佘菲菲. 2009.幽门螺杆菌毒力基因与胃癌的研究进展.福建医科大学学报, 42(3):275~278
吕琳,王丕龙. 2009.重组幽门螺杆菌疫苗的研究现状.重庆医学, 38(8):984~987
孟菁菁,黄大毛,唐发清. 2008.蛋白质与蛋白质相互作用的研究进展.国际病理科学与临床杂志, 28(6):471~476
商熊跃,李敬远,曾因明. 2007.线粒体通透性转运孔道模型的研究进展.国际麻醉学于复苏杂志, 28(2):154~157
沈方,沈倩,夏强. 2005.细胞凋亡与线粒体通透性转变孔的研究进展.浙江大学学报(医学版), 34(2):191~196
唐清,王琳琳. 2006.幽门螺杆菌空泡毒素的作用机制研究进展.广西医科大学学报, 23(1): 162~164
吴丽华. 2007.幽门螺杆菌与胃部疾病关系的研究进展.中国现代医药杂志, 9(11):137~140
徐肇敏,李运红,王亚东,王亚东,陈家范,王宁,张志宏. 1999.江苏省胃癌高发区幽门螺杆
菌感染与胃癌、基因突变之间的关系.中华消化杂志, 19(4):236
杨艺,邓长生,姚学军,刘汉燕,陈默. 2001.幽门螺杆菌对胃上皮细胞系列SGC-7901细胞生长的影响.中华消化杂志, 21(2):113
袁建平,赵蔚,杨贵珍,胡宝瑜,童善庆,郭晓奎. 2003.幽门螺杆菌VacA真核表达载体的构建及其诱导细胞空泡化和凋亡.中国微生态学杂志, 15(2):66~68
张春梅,李松涛,董海波,方耀宗,国冬梅,张蕾蕾. 2006.幽门螺杆菌黏附素的研究.检验医学教育, 13(2):46~48
张红欣,宋文刚,郑成超. 2007.幽门螺杆菌基因工程疫苗的研究进展.细胞与分子免疫学杂志, 23(12):1099~1101
张微,刘纯杰. 2008.幽门螺杆菌致胃癌发生机制.胃肠病学和肝病学杂志,17(3):177~181
赵凌杰,吴旭. 2001.幽门螺杆菌与慢性胃炎及胃癌的关系.华南国防医学杂志, 15(2):21~24
赵雩卿,钱家鸣. 2004.幽门螺杆菌空泡毒素研究进展.胃肠病学和肝病学杂志, 13(3):322~325
Abu-Hamad S, Sivan S, Shoshan-Barmatz V. 2006. The expression level of the voltage-dependent anion channel controls life and death of the cell. Proceedings of the National Academy of Science of USA, 103(15):5787~5792
Aebischer T, Walduch A, Schroeder J,Wehrens A,Chijioke O,Schreiber S,Meyer T F. 2008. A vaccine against Helicobacter pylori:Towards understanding the mechanism of protection. International Journal of Medical Microbiology, 298(1):161~168
Aepulceda A R, Tao H, Carloni E.2002. Screening of gene expression profiles in gastric epithelial cells induces by Helicobacter pylori using micrp array analysis. Alimentary pharmacology & Therapeutics, 16(suppl 2):145~157
AlcaláS, Klee M, Fernández J, Fleische A,Pimentel- Mui?os F X. 2008. A high-throughput screening for mammalian cell death effectors identifies the mitochondrial phosphate carrier as a regulator of cytochrome c release. Oncogene, 27(1):44~54
Ali M, Khan A A, Tiwari S K, Ahmed N, Rao L V, Habibullah C M. 2005. Association between Cag pathogenicity island in Helicobacter pylori isolates from pepticulcer gastric carcinoma and non-ulcer dyspepsia subjects with histological changes. World Journal of Gastroenteology, 11(43):6815~6822
Allen L A, Schlesinger L S, Kang B. 2000. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. Journal of Experimental Medicine, 191(1):115~128
Alm R A, Bina J, Andrews B M, Doig P, Hancock R E-W, Trust T J.2000. Comparative genomics of Helicobacter pylori:analysis of the outer membrane protein families. Infection and Immunity, 68(7):4155~4168
Alm R A, Ling L S,Moir D T, King B L, Brown E D, Doig P C, Smith D S, Noonan B, Guild B C, deJonge B L, Carmel G, Tummino P J, Caruso A, Uria-Nichelsen M, Mills D M, Ives C, Gibson R, Merberg D, Mills S D, Jiang Q, Taylor D E, Vovis G F, Trust T J.1999.Genomic sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori.Nature,397(6715):176~180
Amieva M R, EI-Omar E M.2008.Host-bacterial interactions in Helicobacter pylori infecton. Gasroenterology, 134(1):306~323
Amieva M R, Vogelmann R, Covacci A, Tompkins L S, Nelson W J, Falkow S. 2003. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science, 300(5624):1430~1434
Anderden-Nissen E, Smith K D, Strobe K L, Barrett S L, Cookson B T, Logan S M, Aderem A.2005.Evasion of Toll-like receptor 5 by flagellated bacteria.Proceedings of the National Academy of Sciences of the United States of America, 102(26):9247~9252
An?ous-Pharayra K, Cai Z J, Craigen W J. 2007. VDAC 1 serves as a mitochondrial binding site for hexokinase in oxidative muscles. Biochim Biophys Acta, 1767(2):136~142
Atherton J C, Cao P, Peek R M, Tummuru M K, Blaser M J, Cover T L. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem., 270(30):17771~17777
Atherton J C.2006.The pathogenesis of Helicobacter pylori-induced gastro-duodenal disease.Annual Review of Pathology, 1(2):63~96
Backert S, Selbach M. 2008. Role of typeⅣsecretion in Helicobacter pylori pathogenesis.Cell Microbiology, 10(8):1573~1581
Backstrom A, Lundberg C, Kersulyte D, Berg D E, Boren T, Arnqvist A.2004.Metastability of Helicobacter pylori bab adhesin genes and dynamics in Lewis b antigen binding.Proceedings of the National Academy of Sciences of the United States of America,101(48):16923~16928
Baines C P, Kaiser R A, Sheiko T, Craigen W J, Molkentin J D. 2007. Voltage-dependent anion channels are dispensable for mitoch- ondrial-dependent cell death. Nature Cell Biology, 9(5):550~555
Baines C P, Molkentin J D. 2009b. Adenine nucleotide translocase-1 induces cardiomyocyte deaththrough upregulation of the pro-apoptotic protein Bax. Journal of Molecular Cell Cardiology, 46 (6): 969~977
Baines C P, Kaiser R A, Purcell N H, Blair N S, Osinska H, Hambleton M A, Brunskill E W, Sayen M R, Gottlieb R A, Dorn G W, Robbins J, Molkentin J D. 2005. Loss of cyclophilin D reveals a critical role for mitocho- ndrial permeability transition in cell death. Nature, 434(7033):658~662
Baines C P. 2009. The molecular composition of the mitochondrial permeability transition pore. Journal of Molecular and Cellular Cardiology, 46(2):850~857
Baltrus D A, Amieva M R, Covacci A, Lowe T M, Merrell D S, Ottemann K M, Stein M, Salama N R, Guillemin K.2009.The complete genome sequence of Helicobacter pylori strain G27.Journal of Bacteriology,191(1):447~448
Basso D, Zambon C F, Letley D P, Stranges A, Marchet A, Rhead J L, Schiavon S, Guariso G, Ceroti M, Nitti D, Rugge M, Plebani M, Atherton J C. 2008. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology, 135(1):91~99
Basso E, Fante L, Fowlkes J, Petronilli V, Fortes M A, Bernardi P.2005. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. Journal of Biological Chemistry, 280(5):18558~18561
Beals I L, Grabree J E, Scunes D, Covacci A, Calam J.1996. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology, 8 (7):645~649
Belzacq A S, Jacotot E, Vieira H L, Mistro D, Granville D J, Xie Z, Reed J C, Kroemer G, Brenner C. 2001a. Apoptosis induction by the photosensitizer verteporfin: identification of mitochondrial adenine nucleotide translocator as a critical target. Cancer Research, 61(4):1260~1264
Belzacq A S, Hamel C Ei,Vieira H L, Cohen I, Haouzi D, Metivier D, Marchetti P, Brenner C, Kroemer G. 2001b. Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine,arsenite and CD437. Oncogene, 20 (52): 7579~7587
Belzacq A S, Vieira H L, Verrier F, Vandecasteele G, Cohen I, Prevost M C, Larquet E, Pariselli F, Petit P X, Kahn A, Rizzuto R, Brenner C, Kroemer G. 2003. Bcl-2 and Bax Modulate Adenine Nucleotide Translocase Activity. Cancer Research, 63(2):541~546
Belzacq A S, Vieira H L, Kroemerb G, Brenner C.2002.The adenine nucleotide translocator in apoptosis. Biochimie,84(2):167~176
Blaser M J, Atherton J C. 2004. Helicobacter pylori persistence: biology and disease. Journal of Clinical Investigation, 113(3):321~333
Blaser M J, Atherton J C.2004.Helicobacter pylori persistence:biology and disease.Clinical Investigation, 113(3):321~333
Boquet P, Ricci V, Galmiche A, Gauthier N C.2003.Gastric cell apoptosis and Helicobacter. pylori: has the main function of VacA finally been identified?.Trends in microbiology, 11(9):410~413
Boren T, Falk P, Roth K A, Larson G, Normark S.1993.Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science, 262(5141):1892~1895
Bossy-Wetzel E, Green D R. 1999. Apoptosis:checkpoint at the mitochondrial frontier. Mutation Research, 434(4):243~251
Boya P, Pauleau A L, Poncet D, Gonzalez-Polo R A, Zamzami N, Kroemer G. 2004. Viral proteinstargeting mitochondrial:controlling cell death. Biochimica et Biophysica Acta, 1659(8):178~189
Brandt S, Kwok T, Harting R, Konig W, Backert S. 2005. NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proceedings of the National Academy of Sciences of the United States of America, 102(26):9300~9305
Brandt S, Shafikhani S, Balachandran P. 2007. Use of a novel coinfection system reveals a role for Racl, H-Ras, and Crk II phosphorylation in Helicobacter pylori induced host cell actin cytoskeletal rearrangement. FEMS Immunology and Medical Microbiology, 50(2):190~205
Bras M L, Borgne-Sanchez A, Touat Z, El Dein O S, Deniaud A, Maillier E, Lecellier G, Reboullat D, Lemaire C, Kroemer G, Jacotot E, Brenner C. 2006. Chemosensitization by Knockdown of Adenine Nucleotide Translocase-2.Cancer Research, 66(18):9143~9152
Brdiczka D. 1991. Contact sites between mitochondrial envelope membranes. Structure and function in energy- and protein-transfer. Biochemical Biophysics. Acta, 1071(3):291~312
Brustovetsky N, Klingenberg M. 1996. Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. Biochemistry, 35(26):8483~8488
Cascales E, Christie P J.2003.The versatile bacterial typeⅣsecretion systems.Nature Reviews of Microbiology, 1(2):137~149
Censini S, Lange C, Xiang Z, Crabtree J E, Ghiara P, Borodovsky M, Rappuoli R, Covacci A.1996.cag,A pathogenicity island of Helicobacter pylori,encodes type I-specifuc and disease-associated virulence factors.Proceedings of the National Academy of Sciences of the United States of America,93(25):14648~14653
Ceu F, Wim G V Quint, Ricardo S, Erwin S, John P D, Qing X, Geraldine G M, Richard M P, Martin J B, van Doorm L J. 2000. Genetic organization and heterogeneity of the iceA locus of Helicobacter pylori.Gene, 246(1):59~68
Chauvin C, De Oliveira F, Ronot X, Mousseau M, Leverve X, Fontaine E. 2001. Rotenone inhibits the mitochondrial permeability transition-induced cell death in U937 and KB cells. Journal of Biological Chemistry, 276 (44): 41394~41398
Chen X J. 2002. Induction of an unregulated channel by mutations in adenine nucleotide translocase suggests an explanation for human ophthalmoplegia. Human Molecular Genetics, 16(11):1835~1843
Cho S J, Kang N S, Park S Y, Kim B O, Rhee D K, Pyo S. 2003. Induction of apotosis and expression of apotosis related genes in human epithelial carcinoma cells by Helicoabater pylori VacA toxin. Toxicon, 42(6):601~611
Christian P, Martin S, Roland R, et al.2001.Key importance of the Helicobacter pylori adherence factor Blood Group Antigen Binding Adhesin during chronic gastric inflammation.Cancer Research, 61 (5):1903~1909
Christie P J, Atmakuri K, Krishnamoorthy V, Jakubowski S, Cascales E.2005. Biogenesis, architecture,and function of bacterial typeⅣsecretion systems. Annual Review of Microbiology, 59(10):451~485
Clarke S J, McStay G P, Halestrap A P. 2002. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin D at a different site from cyclosporin A. Journal of Biological Chemistry, 277(38): 34793~34799
Clyne M, Dolan B, Reeves E P.2007.Bacterial factors that mediate colonization of the stomach andvirulence of Helicobacter pylori.FEMS Mictobiology Letters, 268(2):135~143
Colbeck J C, Hansen L M, Fong J M. 2006. Penotypic profile of the outer membrane proteins BabA and BabB in clinical isolates of Helicobacter pylori. Infection and. Immunity, 74(7):4375~4378
Correa P. 1988.A Human model of gastric carcinogenesis.Cancer Research, 48(13):3554~ 3560
Correa P. 1992.Human gastric carcinogenesis: A multistep and multifactorial process-First American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Research, 52 (24):6735~6740
Costantini P, Belzacq A S, Vieira H L, Larochette N, de Pablo M A, Zamzami N, Susin S A, Brenner C, Kroemer G. 2000. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene, 19(2):307~314
Covacci A, Telford J L, Del Giudice G, Parsonner J, Rappuoli R.1999.Helicobacter pylori virulence and genetic geography.Science, 284(5418):1328~1333
Cover T L, Blaser M J. 1992.Purification and characterization of the vacuolating toxin from Helicobacter pylori.Journal of Biological Chemistry, 267(15): 10570~10575
Cover T L, Hanson P I, Heuser J E. 1997. Acid-induced dissociation of VacA,the Helicobacter pylori vacuolating cytotoxin,reveals its pattern of assembly. Journal of Cell Biology, 138(4):759~769
Cover T L, Krishna U S, Israel D A, Peek R M. 2003. Induction of gastric epithelial cell apoptosis by Helicobacter pyori vacuolating cytotoxin. Cancer Research, 63(5):951~957
Cover T L, Tummuru M K, Cao P, Thompson S A, Blaser M J. 1994. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. Journal of Biological Chemistry, 269 (14):10566~10573
Crompton M, Virji S, Ward J M. 1998. Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. European Journal of Biochemistry, 258(2):729~735
Crompton M. 1999. The mitochondrial permeability transition pore and its role in cell death. Biochemical Journal, 341(2):233~249
Croxen M A, Sisson G, Melano R, Hoffman P S.2006.The Helicobacter pylori chemotaxin receptor TlpB(HP0103) is required for pH taxis and for colonization of the gastric mucosa. Bacteriology, 188 (7):2656~2665
Czajkowsky D M, Iwamoto H, Cover T L, Shao Z F. 1999. The vacuolating cytotoxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. Proceedings of the National Academy of Sciences of the United States of America, 96(5):2001~2006
de Bernard M, Arico B, Papini E, Rizzuto R, Grandi G, Rappuoli R, Montecucco C. 1997. Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol. Molecular Microbiology, 26(4):665~674
de Bernard M, Burroni D, Papini E, Rappuoli R, Telford J, Montecucco C. 1998. Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol. Infection and Immunity,66(12):6014~6016
de Bernard M, Moschioni M, Napolitani G, Rappuoli R, Montecucco C. 2000. The VacA toxin of Helicobacter pylori identifies a new intermediate idament-interacting protein. Journal of European Molecular Biology Organization, 19(1):48~56
de Macedo D V, Nepomuceno M E, Pereira-da-Silva L. 1993. Involvement of the ADP/ATP carrier in perme- abilization processes of the inner mitochondrial membrane. European Journal of Biochemistry, 215(3):595~600
Degli E M, Dive C. 2003. Mitochondrial membrane permeabilisation by Bax/Bak. Biochemical and Bioph ysical Research Communications,304(3):455~461
Del Arco A, Agudo M, Satrústegui J. 2000. Characterization of a second member of the subfamily of calcium-binding mitochondrial carriers expressed in human non-excitable tissues. Biochemical Journal, 345(3):725~732
Del Arco A, Satrústegui J. 1998. Molecular cloning of Aralar, a new member of the mitochondrial carrier superfamily that binds calcium and is present in human muscle and brain. Journal of Biological Chemistry, 273(36):23327~23334
Desagher S, Martinou J C. 2000. Mitochondral as the central control point of apoptosis. Trends in Cell Biology, 10(9):369~378
Deschauer M, Hudson G, Muller T, Taylor R W, Chinnery P F, Zierz S. 2005. A novel ANT1 gene mutation with probable germline mosaicism in autosomal dominant p rogressive external phthalmoplegia. Neuromuscular Disorders, 15(4):311~315
Di Lisa F, Canton M, MenabòR, Kaludercic N, Bernardi P. 2007. Mitochondria and cardioprotection. Heart Failure Reviews, 12(3-4):249~260
Di Lisa F, MenabòR, Canton M, Barile M, Bernardi P. 2001. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD + and is a causative event in the death of myocytes in postischemic reperfusion of the heart. Journal of Biological Chemistry, 276(4):2571~2575
Lee A. 1996. Therapeutic immunisation against Helicobacter infection. Gastroenterology, 110(6):914~915
Dolce A, Scarcia P, Iacopetta D, Palmieri F.2005. A fourth ADP /ATP carrier isoform in man:identification, bacterial exp ression, functional characterization and tissue distribution. FEBS Letters, 579 (3): 633~637
Donahue J P, Peek R M, Van Doorn L J, Thompson S A, Qing X, Blaser M J, Miller G G. 2000. Analysis of iceA1 transcription in Helicobacter pylori. Helicobacter, 5(1):1~12
D?rner A, Pauschinger M, Schwimmbeck P L, Kuhl U, Schultheiss H P. 2000. The shift in the myocardial adenine nucleotide translocator isoform expression pattern is ssociated with an enteroviral infection in the absence of an active T-cell dependent immune response in human inflammatory heart disease. Journal of the American College of Cardiology, 35(7):1778~1784
Dorner B G, Scheffold A, Rolph M S. 2002. MIP-1[alpha],MIP-1[beta],RANTES,and ATAC /lymphotactin function together with IFN-[gamma] as type 1 cytokines. Proceedings of the National Academy of Sciences of the United States of America, 99(9):6181~6186
Dundon W G, de Bernard M, Montecucco C. 2001. Virulence factors of Helicobacter pylori. International Journal of Medical Microbiology, 290(2):647~658
Dunn B E, Campbell G P, Perez G I, Blaser M J. 1990. Purification and characterization of urease from Helicobacter pylori. Journal Biological Chemistry, 265(16):9464~9469
Eaton K A, Morgan D R, Krakowka S.1992.Motility as a factor in the colonization of gnotobioticpiglets by Helicobacter pylori.Medical Microbiology, 37(2):123~127
El-Omar E M, Carrington M, Chow W H. 2000. Rabkin CS.Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature, 404(6776):398~402
Eva P P, Cecile D G, Richard K, Veronique T, Guy J M, Gerard B. 2003. Structure of mitochondrial ADP /ATP carrier in comp lex with carboxyatractyloside. Nature, 426(6962):39~44
Eva P P, Gérard B. 2004. Nucleotide exchange in mitochondria:insight at a molecular level. Current Opinion in Structural Biology, 14(4):420~425
Fan X J, Gunasena H, Cheng Z J, Espejo R, Crowe S E, Ernst P B, Reyes V E. 2000. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apotosis. Journal of Immunology,165(4):1918~1924
Ferlay J, Autier P,Boniol M, Heamue M, Colombet M, Boyle P. 2007. Estinates of the cancer incidence and mortality in Europe in 2006. Annals of Oncology,18(3):581~592
Ficher W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. 2001. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island:essential genes for CagA translocation in host cells and induction of interleukin-8. Molecular Mictobiology, 42(5): 1337~1348
Fields S, Song O. 1989. A novel genetic system to detect protein-protein interactions.Nature, 340 (6230):119~125
Fiore C, Trézéguet V, Le Saux A, Roux P, Schwimmer C, Dianoux A C, Noel F, Lauquin G J-M, Brandolin G, Vignais P V. 1998. The mitochondrial ADP/ATP carrier:structural, physiological and pathological aspects. Biochimie, 80(2):137~150
Florence Verrier, Aure′lien Deniaud, Morgane LeBras, Didier Me′tivier, Guido Kroemer, Bernard Mignotte, Gwenae Jan, Catherine Brenner. 2004. Dynamic evolution of the adenine nucleotide translocase interactome during chemotherapy-induced apoptosis.Oncogene,23:8049~8064
Fontaine E, Eriksson O, Ichas F, Bernardi P. 1998. Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation by electron ?ow through the respiratory chain complex I. Journal of Biological Chemistry, 273(20):12662~12668
Forsyth M H, Atherton J C, Blaser M J, Cover T L. 1998. Heterogenetity in levels of vacuolating cytotoxin gene (vacA) transcription among Helicobacter pylori strains. Infection and Immunity, 66(7):3088~3094
Galluzzi L, Aaronson S A, Abrams J, Alnemri E S, Andrews D W, Baehrecke E H, Bazan N G, Blagosklonny M V, Blomgren K, Borner C, Bredesen D E, Brenner C, Castedo M, Cidlowski J A, Ciechanover A, Cohen G M, Laurenzi V D, Maria R D, Deshmukh M, Dynlacht B D, El-Deiry W S, Flavell R A, Fulda S, Garrido C, Golstein P, Gougeon M L, Green D R, Gronemeyer H, Hajnoczky G, Hardwick J M, Hengartner M O, Ichijo H, Jaattela M, Kepp O, Kimchi A, Klionsky D J, Knight R A, Kornbluth S, Kumar S, Levin B, Kroemer G. 2009. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death and Differentiation, 16(4):1093~1107
Galluzzi L, Maiuri M C, Vitale I, Zischka H, Castedo M, Zitvogel L, Kroemer G. 2007. Cell death modalities: classification and pathophysiological implications. Cell Death and Differentiation, 14(7): 1237~1243
Galluzzi L, Morselli E, Kepp O, Vitale I, Rigoni A, Vacchelli E, Michaud M, Zischka H, Castedo M, Kroemer G. 2010. Mitochondrial gateways to cancer. Molecular Aspects of Medicine, 31(1):1~20.
Galmiche A, Rassow J, Doye A, Cagnol S, Chambard J C, Contamin S, V. de Thillot, Just I, Ricci V, Solcia E, Van Obberghen E, Boquet P. 2000. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. Embo. J. 19 (23) 6361~6370
Garc?′a N, Zazueta C, Pavo′n N, Chavez E. 2005. Agaric acid induces mitochondrial permeability transition through its interaction with the adenine nucleotide translocase:Its dependence on membrane fluidity. Mitochondrion, 4(4):272~281
Garcia N, Martinez-Abundis E, Pavon N, Correa F, Chavez E. 2007. Copper induces permeability transition through its interaction with the adenine nucleotide translocase. Cell Biology International, 31(9):893~899
Garner J A, Cover T L. 1996. Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells. Infection and Immunity,64(10):4197~4203
Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. 2003. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science, 301(5636):1099~1102
Glocher E, Lange C,Covacci A, Bereswill S, Kist M, Pahi H L. 1998. Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-κB activation. Infection Immunology, 66(5):2346~2348
Goldmacher V S, Bartle L M, Skaletskaya A, Dionne C A, Kedersha N L, Vatet C A, Han J W, Lutz R J, Watanabe S, McFarland E D, Kieff E D, Mocarski E S, Chittenden T. 1999. A cytomegalovirus-encoded mitochondrialocalized inhibitor of apoptosis structurally unrelated to Bcl-2. Proceedings of National Academy of Sciences of the USA, 96(22):12536~12541
Gomez L, Thibault H, Gharib A, Dumont J M, Vuagniaux G, Scalfaro P, Derumeaux G, Ovize M. 2007. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. American Journal of Physiology, 293(3):1654~1661
Goto S, Chuman H, Majima E, Terada H. 2002. How does the mitochondrial ADP /ATP carrier distinguish transportable ATP and ADP from untransportable AMP and GTP? Dynamic modeling of the recognition /translocation p rocess in the major substrate binding region. Biochim Biophys Acta, 1589(2):203~218
Graham B H, Waymire K G, Cottrell B, Trounce I A, MacGregor G R, Wallace D C. 1997. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nature Genetics, 16(3):226~234
Graham D Y, Malaty H M, Evans D G, Ecans D J, Klein P D, Adam E. 1991. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States: effect of age, race and socioeconomic status.Gastroenterology,100(6):1495~1501
Green D R, Kroemer G.2004.The pathophysiology of mitochondrial cell death.Science,305 (5684): 626~629
Green D R, Reed J C. 1998. Mitochondria and apoptosis. Scienc, 281(5381):1309~1312
Grimm S, Brdiczka D. 2007. The permeability transition pore in cell death. Apoptosis, 12(2): Gupta V R, Patel H K, Kostolansky S S, Ballivian R A, Eichberg J, Blanke S R. 2008.
Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA. PLOS Pathogens, 4(5):1~12
Halestrap A P, Clarke S J, Javadov S A. 2004. Mitochondrial permeability transition pore openingduring myocardial reperfusion—a target for cardioprotection. Cardiovascular Research, 61(3):372~385
Halestrap A P, Davidson A M. 1990. Inhibition of Ca2+-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochemistry, 268(8):153~160
Leung A W C, Halestrap A P. 2008. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochimica et Biophysica Acta,1777(7-8):946-952.
Halestrap A P, Woodfield K Y, Connern C P. 1997. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. Journal of Biological Chemistry, 272(6):3346~3354
Halestrap A, McStay G P, Clarke S J. 2002. The permeability transition pore complex:another view. Biochime, 84(2):153~166
Han S R, Schreiber H J, Bhakdi S, Loos M, Maeurer M J. 1998. VacA genotypes and genetic diversity in clinical isolates of Helicobacter pylori. Clinical Diagnosis Lab Immunology, 5(2):139~145
Hashimoto M, Majima E, Hatanaka T, Shinohara Y, Onishi M, Goto S, Terada H. 2000. Irreversible extrusion of the first loop facing thematrix of the bovine heartmitochondrialADP /ATP carrier by labeling the Cys56 residue with the SH-reagent methylmethanethiosulfonate. Journal of Biochemistry, 127(3):443~449
Hausenloy D J, Duchen M R, Yellon D M. 2003. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia–reperfusion injury. Cardiovascular Research, 60(3):617~625
Haworth R A, Hunter D R. 2000. Control of themitochondrial permeability transition pore by high-affinity ADP binding at the ADP/ATP translocase in permeabilized mitochondria. Journal of Bioenergetics and Biomembranes, 32(1):91~96
Held M, Engstrand L, Hansson L E, Bergstrom R, Wadstrom T, Nyren O. 2004. Is the association between Helicobacter pylori and gastric cancer confined to CagA positive strains. Helicobacter, 9(3):271~277
Hennig E E, Butruk E, Ostrowski J.2001.RACK1 protein interacts with Helicobacter pylori VacA cytotoxin:the yeast two-hybrid approach.Biochemical and Biophysical Research Communications, 289(1):103~110
Hennig E E, Godlewski M M, Butruk E, Osteowski J. 2005. Helicobacter pylori VacA cytotoxin interacts with fibronectin and alters HeLa cell adhesion and cytoskeletal organization in vitro. FEMS Immunology and Medical Microbiology, 44(1):143~150
Tsuge H, Tsurumura T, Utsunomiya H, Kise D, Kuzuhara T, Watanabe T, Fujiki H, Suganima M. 2009. Structural basis for the Helicobacter pylori carcinogenic TNF -α-inducing protein. Biochemical and Biophysical Research Communications, 388(2):193~198
Higashi H, Nakaya A, Tsutsumi R, Yokoyama K, Fujii Y, Ishikawa S, Higuchi M, Takahashi A, Kurashima Y, Teishikata Y, Tanaka S, Azuma T, Hatakeyama M. 2004. Helicobacter pylori CagA induced Ras-independeng morphogenetic response through Shp-2 recruitment and activation. Journal of Biological Chemistry, 279(17):17205~17216
Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M. 2002. Shp-2tyrosine phosphataseas an intracellular target of Helicobacter pylori CagA protein. Science, 295(5555):683~686
Hoda M, Malaty.2007.Epidemiology of Helicobacter pylori infection.Best Practice & Research:Clinical Gastroenterology,21(2):205~214
Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. 1998. Development of Helicobacter pylori-induced gastric caicinoma in Mongolian gerbils.Cancer Research, 58(19):4255~4259
Ikenoue T, Maeda S, Ogura K, Akanuma M, Mitsuno Y, Imai Y, Yoshida H, Shiratori Y, Omata M. 2001. Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clinical and Diagnostic Laboratory Immunology, 8(1):181~186
Ilver D, Arnqvist A, Ogren J, et al.1998.Helicobacter pylori adhesion binding fucosylated histo-blood group antigens revealed by retagging. Science, 279(5349):373~377
International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori:Views and Expert Opinions of an IARC Working Group on theEvaluation of Carcinogenic Risks to Humans.1994.Lyon France,IARC Press, 6:177~240
Ito Y, Azuma T, Ito S, Miyaji H, Yamazaki Y, Sato F, Kato T, Kohli Y, Kuriyama M. 1997. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. Journal of Clinical Microbiology, 35(7):1710~1714
Iwamoto H, Czajkowsky D M, Cover T L, Szabo G, Shao Z F. 1999. VacA from Helicobacter pylori a hexameric chloride channel. FEBS Letter, 450(1):101~104
Jacotot E, Ferri K F, Hamel C E, Brenner C, Druillennec S, Hoebeke J, Rutin P, Metivier D, Lenoir C, Geuskens M, Vieira H L, Loeffler M, Belzacq A S, Briand J P, Zamzami N, Edelman L, Xie Z H, Reed J C, Roques B P, Kroemer G. 2001. Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. Journal of Experiment Medicine,193(4):509~519
Jacotot E, Ravagnan L, Loeffler M, Ferri K F, Vieira H L A, Zamzami N, Costantini P, Druillennec S, Hoebeke J, Briand J P, Irinopoulou T, Daugas E, Susin S A, Cointe D, Xie Z H, Reed J C, Roques B P, Kroemer G. 2000. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Experimental Medicine, 191(1):33~46
Jan G, Belzacq A S, Haouzi D, Rouault A, Metivier D, Kroemer G, Brenner C. 2002. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death and Differentiation, 9(2):179~188
Jorge O, Carrion F D, Jorge A, Ciocca D R. 2003. Helicobacter pylori infection affects the expression of PCNA,p53,c-erbB-2 and Bcl-2 in the human gastric mucosa. Reviews Espanish Enferm Digestive, 95(2):97~104
Kimura M,Goto S, Wada A, Yahiro K, Niidome T, Hatakeyama T, Aoyagi H, Hirayama T, Kondo T. 1999. Vacuolating cytotoxin purified from Helicobacter pylori cause mitochondrial damage in human gastric cells. Microbial Pathogenesis,26(1):45~52
Kluck R M, Bossy-Wetzel E, Green D R, Newmeyer D D. 1997. The release of cytochrome c from Mitochondria:A primary site for Bcl-2 regulation of apoptosis. Science, 275(5303):1132~ 1136
Kokoszka J E, Waymire K G, Levy S E, Sligh J E, Cai J Y, Jones D P, MacGregor G R, Wallace DC. 2004. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature, 427(6973):461~465
Kroemer G, El-Deiry W S, Golstein P, Peter M E, Vaux D, Vandenabeele P, Zhivotovsky B, Blagosklonny M V, Malorni W, Knight R A, Piacentini M,Nagata S, Melino G. 2005. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death and Differentiation, 12(sup 2):1463~1467
Kroemer G, Galluzzi L,Brenner C. 2007. Mitochondrial membrane permeabilization in cell death. Physiology Reviews,2007,87(1):99–163.
Kuck D, Kolmerer B, Iking-Konert C, Krammer P H, Stremmel W, Rudi J. 2001. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS.Infection and Immunity,69 (8):5080~5087
Kudo T, Nurgalieva Z Z, Conner M E, Crawford S, Odenbreit S, Haas R, Graham D Y, Yamaoka Y. 2004. Correlation between Helicobacter pylori OipA protein expression and OipA gene switch status. Journal of Clinical Microbiology, 42 (5): 2279~2281
Kuo C H, Wang W C. 2003. Binding and internalization of Helicobacter pylori VacA via cellular lipid rafts in epithelial cells. Biochemical and Biophysical Research Communications, 303(2):640~644
Kusters J G, van Vliet A H, Kuipers E J.2006.Pathogenesis of Helicobacter pylori infecton. Clinical Microbiology Reviews, 19(3):449~490
Kuzuhara T, Suganuma M, Kurusu M, Fujiki H. 2007. Helicobacter pylori-secreting protein Tipa is a potent inducer of chemokine gene expressions in stomach cancer cells. Cancer Research Clinical Oncology, 133(5):287~296
Kuzuhara T, Suganuma M, Oka K,Fujiki H. 2007. DNA-binding activity of TNF-a inducing protein from Helicobacter pylori. Biochemical and Biophysical Research Communications, 362(4):805~810
Lanzavecchia S, Bellon P L, Lupetti P, Dallai R, Rappuoli R, Telford J L. 1998. Three-dimensional reconstruction of metal replicas of the Helicobacter pylori vacuolating cytotoxin. Journal of Structural Biology, 121(1):9~18
Larche J, Lancel S, Hassoun S M, Favory R, Decoster B, Marchetti P, Chopin C, Neviere R. 2006.
Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality. Journal of American College of Cardiology, 48(2):377~385
Lee K M, Lee D S, Yang J M, Ahn B M, Lee E H, Yoo J Y, Chung I S, Sun H S, Park D H. 2003.
Effect of Helicobacter pylori on gastric epithelial cell kinetics and expression of apotosis-related proteins in gastric carcinogenesis. Korean Journal of Gastroenterol,42(1):12~19
Letley D P, Lastovica A, Louw J A, Hawkey C J, Atherton J C. 1999. Allelic diversity of the Helicobacter pyori vacuolating cytotoxin gene in South Africa:Rarity of the vacA s1a genotype and natural occurrence of an s2/m1 allele. Journal of Clinical Microbiology, 37(4):1203~1205
Leung A W, Varanyuwatana P, Halestrap A P. 2008. The mitochondrial phosphate carrier interacts with cyclophilin D andmay play a key role in the permeability transition. Journal of Biological Chemistry, 283(39):26312~26323
Leunk R D, Johnson P T, David B C, Kraft W G, Morgan D R. 1988. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med. Microbiol. 26 (2):93~99
Lu H, Hsu P I, Graham D Y, Yamaoka Y. 2005. Duodenal ulcer promoting gene of Helicobacterpylori. Gastroenterology, 128(4):833~848
Gomes L I, Rocha G A , Rocha A M C, Soares T F, Oliveira C A, Bittencourt P F S, Queiroz D M M. 2008. Lack of association between Helicobacter pylori infection with dupA-positive strains and gastroduodenal disease in Brizilian patiens. International Journal of Medical Microbiology, 298(3):223~230
Lupetti P, Heuser J E, ManeHi R, Massari P, Lanzavecchia S, Bellon P L, Dallai R, Eappuoli R, Telford J L. 1996. Oligomeric and subuit structure of the Helicobacter pylori vacuolating cytotoxin. Journal of Cell Biology, 133(4):801~807
Machida K, Hayashi Y, Osada H. 2002. A Novel Adenine Nucleotide Translocase Inhibitor, MT-21,Induces Cytochrome c Release by a Mitochondrial Permeability Transition- independent Mechanism. Journal of Biological Chemistry, 277(34):31243~31248
Maeda S,Yoshida H, Mitsuno Y, Hirata Y, Ogura K, Shiratori Y, Omata M. 2002. Analysis of apotosis and antiapotosis signaling pathways induced by Helicobacter pylori.Gut, 50(6): 771~778
Mahdavi J, Sonden B, Hurtig M, Olfat F O, Forsberg L, Roche N, Angstrom J, Larsson T, Teneberg S, Karlsson K A, Altraja S, Wadstrom T, Kersulyte D, Berg D E, Dubois A, Petersson C, Magnusson K E, Borberg T, Lindh F, Lundskog B, Arnqvist A, Hammarstrom L, Boren T. 2002. Helicobacter pylori SabA adhesin in persistent infection and chronic in?ammation. Science, 297(5581):573~578
Manente L, Perna A, Buommino E, Altucci L, Lucariello A, Citro G, Baldi A, Iaquinto G, Tufano M A, De Luca A. 2008. The Helicobacter pylori’s protein VacA has direct effects on the regulation of cell cycle and apoptosis in gastric epithelial cells. J. Cell Physiol,214 (3) 582~587
Manetti R, Masari P, Burroni D, de Bernard M, Marcini A, Olivieri R, Papini E, Montecucco C, Rappuoli R, Telford J L. 1995. Helicobacter pylori cytotoxin:importance of native conformation for induction of neutralizing antibodies. Infection and Immunity, 63(11): 4476~4480
Marchi U D, Campello S, SzabòI, Tombola F, Martinou J C, Zoratti M. 2004. Bax Does Not Directly Participate in the Ca2+-induced Permeability Transition of Isolated Mitochondria. Biological Chemistry, 279(5):37415~37422
Marina A H, Giedrius D, Martins L, Kalia A, Ilver D, Roche N, Vikstrom S, Sjostrom R, Linden S, Bachstrom A, Lundberg C, Arnqvist A, Mahdavi J, Nilsson U J, Velapatino B, Gilman R H, Gerhard M, Alarcon T, Lopez-Brea M, Nakazawa T, Fox J G, Correa P, Dominguez-Bello M G, Perez-Perez G I, Blaser M J, Normark S, Carlstedt I, Oscarson S, Teneberg S, Berg D E, Boren T. 2004. Functional adaptation of BabA, the Helicobacter pylori ABO Blood Group Antigen Binding Adhesin. Science,305(5683):519~522
Marshall B J,Warren J R.1984.Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceratiom.Laccet,1(8390):1311~1315
Marshall B J. 1994. Helicobacter pylori. American Journal of Gastroenterology, 89(2):116~128
Marzo I, Brenner C, Zamzami N, Susin S A, Beutner G, Brdiczka D, Remy R, Xie Z H, Reed J C, Kroemer G. 1998b. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. Journal of Experimental Medicine, 187(8): 1261~1271
Marzo I, Brenner C, Zamzami N, Jyrgensmeier J M, Susin S A, Vieira H L A, Prevost M C, Xie Z H, Matsuyama S, Reed J C, Kroemer G. 1998a. Bax and Adenine Nucleotide Translocator cooperate in the mitochondrial control of apoptosis. Science,281(5385):2027~2031
Massari P, Manetti R, Burroni D, Nuti S, Norais N, Rappuoli R, Telford J L. 1998. Binding of theHelicobacter pylori vacuolating cytotoxin to target cells. Infecton and Immunity, 66(8):3981~3984
Mattar R, Marques S B, Monteiro M S, dos Santos A F, Iriya K, Carrilho F J. 2007. Helicobacter pylori cag pathogenicity island genes:clinical relevance for peptic ulcer disease development in Brazil. Journal of Medical Microbiology, 56(1):9~14
Mayer B, Oberbauer R. 2003. Mitochondrial regulation of apoptosis. News in Physiological Sciences, 18(6):89~94
Mayer B, Oberbauer R. 2003. Mitochondrial regulation of apoptosis.News in Physiological Sciences,18(5):89~94
McClain M S, Schraw W, Ricci V, Boquet P, Cover T L. 2000. Acid activation of Helicobacter pylori vacuolating cytotocin(VacA) results in toxin internalization by eukalyotic cells. Molecular Microbiology, 7(2):433~442
McClain M S, Cao P, Iwamoto H, Vinion-Dubiel A D, Szabo G, Shao Z, Cover T L. 2001.
A12-amino-acid Segment,present in type s2 but not type s1 Helicobacter pylory VacA Proteins,Abolishes cytotoxin activity and alters membrane channel Formation. Journal of bacteriology, 183(22):6499~6508
McGee D J, Langford M L, Watson E L, Carter J E, Chen Y T, Ottemann K M. 2005. Colonization and inflammation deficiencies in Mongolian gerbils infected by Helicobacter pylori chemotaxis mutants. Infection and Immunity, 73 (3):1820~1827
McNamara D, EI-Omar E. 2008. Helicobacter pylori infection and the pathogensis of gastric cancer:A paradigm for host-bacterial interactions. Digestive and Liver Disease, 40(7): 504~509
Menaker R J, Ceponis P J, Jones N L.2004.Helicobacter pylori induces apotosis of Macrophages in association with alteration in the mitochondrial pathway.Infection and Immunity, 72(5):2889~2898
Merrell D S, Goodrich M L, Otto G, Tompkins L S, Falkow S. 2003. pH-regulated gene expression of the gastric pathogen Helicobacter pylori. Infection and Immunology, 71(6):3529~ 3539
Michetti P, Corthesy-Theulaz I, Davin C, et al. 1994. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology, 107(4):1002~1011
Minuro H, Suznki T, Tanaka J, Asahi M, Haas R, Sasakawa C. 2002. Grb2 is a key mediator of cagA protein activities. Molecular Cell, 10(4):745~755
Mireille B, Gerard B, Michel S, Gerard K. 1999. The mitochondria adenine nucleotide translocator from dictyostelium: functional characterization and DNA sequancing. European Journal of Biochemistry, 259(3):795~800
Miyamoto S, Murphy A N, Brown J H. 2008. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death and Differentiation, 15 (3):521~529
Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn S J. 1997. Murine CD4 T-cell response to Helicobacter infection:TH1 cells enhance gastritis and TH2 cell reduce bacterial load. Gastroenterology, 113(6):848~857
Mohammadi M, Oghalaie A, Mohajerani N, Massarrat S, Nasiri M, Bennedsen M, Colding H, Andersen L P. 2003. Prevalence of Helicobacter pylori vacuolating cytotoxin and its allelic mosaicism as a predictive marker for Iranian dyspeptic patients. Bulletin Society Pathological Exotique, 96(1):3~5
Mohammadi M, Redline R, Nedrud J, Nedrid J. 1996. Helicobacter specific cell mediated immune resposes display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in thestomach of mice. Journal of Immunology, 156(12):4729~4738
Molinari M, Galli C, Norais N, Telford J L, Rappuoli R, Luzio J P, Montecucco C. 1997. Vacuoles induced by Helicobacter pylori toxin contain both lateendosomal and lysosomal markers. Journal of Biological Chemistry, 272(40):25339~25344
Molinari M, Salio M, Galli C, Norais N, Rappuoli R, Lanzavecchia A, Montecucco C. 1998.
Selective inhibihton of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. Journal of Experimental Medicine, 187(1):135~140
Morbiato L, Tombola F, Campello S. 2001. Vacuolation induced by VacA toxin of Helicobacter pylori requires the intracellularaccumulation of membrane permeant bases,C1 and water. FEBS Letter, 508(3):479~483
Moss S F, Sordillo E M, Abdalla A M, Makarov V, Hanzely Z, Perez-Perez G I, Blaser M J, Holt P R. 2001. Increased gastric epithelial cell apoptosis associated with colonization with CagA+ Helicobacter pylori strains. Cancer Research, 61(4):1406~1411
Murphy E, Steenbergen C. 2008. Mechanisms underlying acute protection from cardiac ischemia–reperfusion injury. Physiological Reviews, 88(2):581~609
Mutata K N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek R M, Azuma T, Hatakeyama M. 2007. Helicobacter pylori CagA interacts with E-cadherin and deregulates theβ-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene, 26(32):4617~4626
Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T, Tsujimoto Y. 2005. CyclophilinD-dependentmitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature, 434(7033):652~658
Natio M, Yamazaki T, Tsutsumi R, Higashi H, Onoe K, Yamazaki S, Azuma T, Hatakeyama M. 2006.
Influence of EPIYA repeat polymorphism on the phosphorylation dependent biological activity of Helicobacter pylori CagA. Gastroenterology, 130(4):1181~1190
Neu B, Randlkofer P, Neubhofer M, Voland P, Mayerhofer A, Gerhard M, Schepp W, Prinz C. 2002.
Helicobacter pyori induces apoptosis of rat gastric parietal cells. American Journal of Physiology Gastrointestinal and Liver Physiology, 283(2):309~318
Notario B, Zamora M, Vinas O, Mampel T. 2003. All-trans-Retinoic Acid Binds to and Inhibits Adenine Nucleotide Translocase and induces Mitochondrial Permeability Transition. Molecular Pharmacology,63 (1):224~231
Odenbreit S. 2007. Adherence properties of Helicobacter pylori:impaction pathogenisis and adaptation to the host. International Journal of Medical Microbiology, 295(5):317~324
Oh J D, King-Backhed H, Giannakis M, Xu J, Fulton R S, Fulton L A, Cordum H S, Wang C Y, Elliott G, Edwards J, Mardis E R, Engstrand L G, Gordon J I. 2006. The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain:evolution during disease progression. Proceedings of the National Academy of Sciences of the United States of America, 103(26):9999~10004
Owen R J, Sharp S, Lawson A J, Durrani Z, Rijpkema S, Kidd M. 2003. Investigation of the biological relevance of Helicobacter pylori cage locus diversity,presence of CagA tyrosine phosphorylation motifs and vacuolating cytotoxin genotype on IL-8 induction in gastric epithelial cells. FEMS Immunology & Medical Microbiology, 36(3):135~140
Padilla P I, Wada A, Yahiro K, et al. 2000. Morphologic differentiation of HL-60 cells is associated with appearance of RPTPβand induction of Helicobacter pylori VacA sensitivity. Journal of Biological Chemisry, 275(3):15200~15206
Pagliaccia C, de Bernard M, Lupetti P, Ji X, Burroni D, Cover T L, Papini E, Rappuoli R, Telford J L, Reyrat J M. 1998. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc. Natl. Acad. Sci. USA ,95(17):10212~10217
Pai R, Cover T L, Tarnawski A S. 1999. Helicobacter pylori Vacuolating cytotoxin disorganizes the cytoskeletal architecture of gastric epithelial cells. Biochemical and Biophysical Research Communications, 262(7):245~250
Palmier F. 2004. The mitochondrial transporter family(SLC25):physiological and pathological implications. Pflügers Archiv European Journal of Physiology, 447(5):689~709
Papini E, de Bernard M, Milia E, Bugnoli M, Zerial M, Rappuoli R, Montecucco C. 1994. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc. Natl. Acad. Sci.USA ,91 (21):9720~9724
Papini E, Satin B, Bucci C, de Bernard M, Telford J L, Manetti R, Rappuoli R, Zerial M, Montecucco C. 1997. The small GTP binding protein rab7 is essential for cellular vacuolation induced by Helicobacter pylori cytotoxin. Journal of European Molecular Biology Organization, 16(1):15~24
Papini E, Satin B, Norais N, de Bernard M, Telford J L, Rappuoli R, Montecucco C. 1998. Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pyori cacuolating toxin. Journal of Clinical Investigation, 102 (4): 813~820
Papini E, Zoratti M, Cover T L. 2001. In search of the Helicobacter pylori VacA mechanism of action. Toxincon, 39(1):1757~1767
Papini E, Zoratti M, Cover T L. 2001. In search of the Helicobacter pylori VacA mechanism of action. Toxicon , 39(11):1757~1767
Parsonnet J.1993. Helicobacter pylori and gastric cancer. Gastroenterology Clinics North American, 22(1):89
Patel H K, Wiihite D C, Patel R M, Ye D, Williams C L, Torres E M, Marty K B, MacDonald R A, Blanke S R. 2002. Plasm membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin. Infectio and Immunity, 70(8):4112~ 4123
Pedersen P L. 2007. The cancer cell’s‘‘power plants”as promising therapeutic targets: an overview. Journal of Bioenergetics and Biomembrane, 39(1):1~12
Peek R M Jr, Thompson S A, Donahue J P, Tham K T, Atherton J C, Blaser M J, Miller G G. 1998.
Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proceedings of the Association of American Physicians , 110(6):531~544
Peek R M, Blaser M J.2002.Helicobacter pylori and gastrointestinal tract adenocarcinomas.Nature Reviews Cancer,2(1):28~37
Peek R M, Crabtree E.2006.Helicobacter pylori infection and gastric neoplasia.Journal of Pathology,208(2):233~234
Phadnis S H, IIver D, Janzon L, Normark S, Westblom T U. 1994. Pathological significance and molecular chatacterization of the vacuolating toxin gene of Helicobacter pylori. Infection and Immunity, 62(5):1557~1565
Piantadosi C A, Carraway M S, Suliman H B. 2006. Suliman. Carbon monoxide, oxidative stress, and mitochondrial permeability pore transition. Free Radical Biology and Medicine, 40(8): 1332~1339
Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung T T, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, Andre-Fouet X, Revel D, Kirkorian G, Monassier J P, Derumeaux G, Ovize M. 2008. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. New England Journal of Medicine, 359(5):473~481
Proenca J L, Lopes A I, Acrani G O, Russo R, Ribeiro M A, Fukuhara Y, da Silveira W D, Modena J L, de Oliveiea R B, Brocchi M. 2007. Association between Helicobacter pylori genotypes and gastric disorders in relation to the cag pathogenicity island. Diagnostic Microbiology and Infectious Disease, 59(1):7~16
Proenca-Modena J L, Acrani G O, Brocchi M.2009.Helicobacter pylori:phenotypes,genotypes and virulence genes.Future Microbiology, 4(2):223~240
Rain J C, Selig L, De Reuse H, Battaglia V, Reverdy C, Simon S, Lenzen G, Petel F, Wojcik J, Schachter V, Chemama Y, Labigne A, Legrain P. 2001. The protein-protein interaction map of Helocobacter pylori. Nature , 409(6817):211~215
Ramírez R A, Sánchez S R.2009.Helicobacter Pylori 25 years after (1983 -2008): epidemiology, microbiology,pathogenics,diagnostics and treatment.Revista de Gastroenterologia del Peru, 29(2):158~170
Reichert A S, Neupert W. 2004. Mitochondriomics or what makes us breathe. Trends in Genetics, 20(11):555~562
Reyrat J M, Lanzavecchia S, Lupetti P, de Bernard M, Pagliaccia C, Pelicic V, Charrel M, Ulivieri C, Norais N, Ji X H, Cabiaux V, Papini E, Rappuoli R, Telford J L. 1999. 3 D imaging of the 58 kD cell binding subunit of the Helicobacter pylori cytotoxin. Journal of Molecular Biology, 290(2):459~470
Ricci V, Sommi P, Fiocca R, Romano M, Solcia E, Ventura U. 1997. Helicobacter pylori vacuolating toxin accumulates with in the endosomal-vacuolar compartment of cultured gastric cells and potentiates the vacuolating activity ammonia. Journal of Pathology,183(4):453~459
Robinson K.2007.The inflammatory and immune response to Helicobacter pylori infection.Best Practice & Research Clinical Gastroenterology, 21(2):237~259
Roche N, Ilver D, Angstrom J, Barone S, Telford J L, Tenberg S. 2007. Human gastric glycosphingolipids recognized by Helicobacter pylori vacuolating cytotoxin VacA. Microbes and Infection, 9(5):605~614
Rostovtseva T K, Tan W, Colombini M. 2005. On the role of VDAC in apoptosis: fact and fiction. Journal of Bioenergetics and Biomembranes, 37(3):129~142
Rück A, Dolder M, Wallimann T, Brdiczka D. 1998. Reconstituted adenine nucleotide translocase forms a channel for small molecules comparable to the mitochondrial permeability transition pore. FEBS Letters, 426(1):97~101
Saadat I, Higashi H, Obuse C, et al. 2007. Helicobacter pylori CagA targets PARI/MARK kinase to disrupt epithelial cell polarity. Nature, 447(7124):330~333
Sachs G, Weeks D L, Wen Y, Marcus E A, Scott D R. 2005. Acid acclimation by Helicobacter pylori. Physiology (Bethesda), 20(12):429~438
Schinzel A C, Takeuchi O, Huang Z H, Fisher J K, Zhou Z P, Rubens J, Hetz C, Danial N N, Moskowitz M A, Korsmeyer S J. 2005. Cyclophilin D is a component of mitochondrial permeabilitytransition and mediates neuronal cell death after focal cerebral ischemia. Proceeding of National Academy of Sciences of USA, 102(34):12005~12010
Schmitt W, Haas R. 1994. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin:structural similarities with the IgA protease type of exported protein. Molecular Microbiology, 12(2): 307~319
Schraw W, Li Y, McClain M S, van der Goot F, Cover T L. 2002. Association of Helicobacter pylori vacuolating toxin(VacA) with lipid rafts. Journal of Biological Chemistry, 277(37):34642~34650
Schultheiss H P, Schulze K, Kuhl U, Ulrich G, Klingenberg M. 1986. The ADP/ATP carrier as a mitochondrial auto-antigen--facts and perspectives. Annals of the New York Academy of Sciences, 488(7):44~64
Sebastian R D, Bruno G, Ling L, Hans F. 2005. Identification of two new Helicobacter pylori surface proteins involved in attachment to epithelial cell lines. Journal of Medical Microbiology, 54(5):427~434
Selbach M, Moese S, Hurwitz R, Hauck C R, Meyer T F, Backert S. 2003. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. European Molecular Biology Organizition Journal, 22(3):515~528
Seto K, Hayashi-Kuwabara Y, Yoneta T, Suda H, Tamaki H. 1998. Vacuolation induced by cytotoxin from Helicobacter pylori is mediated by receptor in Hela cells. FEBS Letter, 431(3):347~350
Shibata W, Hirata Y, Maeda S, Ogura K, Ohmae T, Yanai A, Mitsuno Y, Okamoto M, Yoshida H, Kawabe T, Omata M. 2006. CagA protein secreted by the intact typeⅣsecretion system leads to gastric epithelial inflammation in the Mobgolian gerbil model. Journal of Pathology, 210(3): 306~314
Shimizu S, Matsuoka Y, Shinohara Y, Yoneda Y, Tsujimoto Y. 2001. Essential role of voltage-dependent anion channel in vario- us forms of apoptosis in mammalian cells. The Journal of Cell Biology, 152(2):237~250
Shimizu S, Narita M,Tsujimoto. 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 399(6735):483~487
Solnick J V, Hansen L M, Salama N R, Boonjakuakul J K, Syvanen M. 2004. Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques. Proceedings of the National Academy of Sciences of the United States of America, 101(7):2106~2111
Stephane G, Christelle B B, Micheline W L. 1998. Expression of human ANT2 gene in highly p roliferative cells: GRBOX, a new transcrip tional element,is involved in the regulation of glycoloytic ATP into mitochondria. Molecular Biology, 281(3):409~418
Stingl K, De Reuse H. 2005.Staying alive overdosed:how does Helicobacter pylori control urease activity?.International Journal of Medical Microbiology, 295(5):307~315
Strobel S, Bereswill S, Balig P, Allgaier P, Sonntag H G, Kist M. 1998. Identification and analysis of a new VacA genotype variant of Helicobacter pylori in different patient groups in Germany. Journal of Clinical Microbiology, 36 (5):1285~1289
Suganuma M, Kurusu M, Suzuki K, Nishizono A, Murakami K, Fujioka T, Fujuki H. 2005. New tumor necrosis factor-a-inducing protein released from Helicobacter pylori for gastric cancer progression. Cancer Research Clinical Oncology, 131(5):305~313
Suganuma M, Kuzuhara T, Yamaguchi K, Fujiki H. 2006. Carcinogenic role of tumor necrosis factor-a inducing protein of Helicobacter pylori in human stomach. Biochemistry and Molecular. Biology,39, (1): 1~8
Suganuma M, Yamaguchi K, OnoY, Matsumoto H, Hayashi T, Ogawa T, Imai K, Kuzuhara T, Nishizono A, Fujiki H. 2008. TNF-α-inducing protein, a carcinogenic factor secreted from Helicobacter pylori, enters gastric cancer cells. International Journal of Cancer, 123(1): 117~122
Sun L, Shukair S, Naik T J, Moazed F, Ardehali H. 2008. Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Molecular and Cell Biology, 28(3):1007~1017
Sundrud M S, Torres V J, Unutmaz D, Cover T L. 2004. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proceedings of National Academyof Sciences of the USA, 101(20):7727~7732
Supajatura V, Ushio H, Wada A, Yahiro K, Okumura K, Ogawa H, Hirayama T, Ra C. 2002. VacA,a vacuolating cytotoxin of Helicobacter pylori,directly activates mast cells for migration and production of proinflammatory cytokines. Immunogy, 168(6):2603~2607
Suzuki M, Mimuro H, Suzuki T, Park M, Yamamoto T, Sasakawa C. 2005. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. Journal of Experimental Medicine, 202(9):1235~1247
Szabo I, Brutsche S, Tombola F, Moschioni M, Satin B, Telford J L, Rappuoli R, Montecucc C, Papini E, Zoratti M. 1999. Formation of anion selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. Journal of European Molecular Biology Organization, 18(20):5517~5527
SzabóI, De Pinto V, ZorattiM. 1993b. Themitochondrial permeability transition poremay comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitoch- ondrial megachannel. FEBS Letters, 330(2): 206~210
SzabóI, Zoratti M. 1993a. The mitochondrial permeability transition pore may comprise VDACmolecules. I. Binary structure and voltage dependence of the pore. FEBS Letters, 330(2): 201~105
Szaleczky E, Pronai L, Molnar B, Berczi L, Feher J, Tulassay Z. 2000. Increased cell proliferation in chronic Helicobacter pylori positive gastritis and gastric carcinoma correlation between immunohistochemistry and TV image cytometry. Analytical Cellular Pathology, 20(2):131~139
Talebkhan Y, Mohammadi M. 2003. Vacuolating cytotoxin of Helicobacter pylori. Iranian Journal of Biotechnology, 1(2):73~81
Tammer I, Brandt S, Harting R, Konig W, Backert S. 2007. Activation of Abl by Helicobacrer pylori:a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology, 132(4):1309~1319
Tan W, Colombini M. 2007. VDAC closure increases calcium ion ?ux. Biochimical Biophysical Acta, 1768(10):2510~2515
Telford J L, Ghiara P, Dell’Ocro M, Comanducci M, Burroni D, Bugnili M, Tecce M F, Cenisini S, Covacci A, Xiang Z. 1994. Gene structure of the Helicobater pylori cytotoxin and evidence of its key role in gastric disease. Journal of Experiment Medicine, 179(5):1653~1658
Tikhonova I M, Andreyev A Yu, Antonenko Yu N, Kaulen A D, Komrakov A Y, Skulachev V P. 1994. Ion permeability induced in artificial membranes by the ATP/ADP Antiporter. FEBS Letters, 337(3):231~234
Tomb J E, White O, Kerlavage A R, Clayton R A, Sutton G G, Fleischmann R D, Ketchum K A, Klenk H P, Gill S, Dougherty B A, Nelson K, Quachenbush J, Zhou L X, Kirkness E F, Peterson S, Loftys B, Richardson D, Dodson R, Khalak H G, Glodek A< McKenney K, Fitzegerald L M, Lee N, Adams M D, Hichey E K, Berg D E, Gocayne J D, Utterback T R, Peterson J D, Kelley J M, Cotton M D, Weidman J M, Fujii C, Bowman C, Watthey L, Wallin E, Hayes W S, Borodovsky M, Karp P D, Smith H O, Fraser C M, Venter J C. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature,388(6642):539~547
Tombola F, Carlesso C, Szabo I, de Bernard M. 1999. Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers:possible implications for the mechanism of cellular vacuolation. Biophysical Journal, 76(3):1401~1409
Tombola F, Morbiato L, del Giudice G, Rappuoli R, Zoratti M, Papini E. 2001. The Helicobacter pyori VacA toxin is a urea permease that promotes urea diffusion across epithelia. Journal of Clinical Investigation, 108(5):929~937
Tosi T, Cioci G, Jouravleva K, Dian C, Terradot L. 2009. Structure of the tumor necrosis factorαindecing protein Tipα:A novel virulence factor from Helicobacter pylori. FEBS Letters, 583(10):1581~1585
Tonazzi A, Indiveri C. 2003. Chemical modification of the mitochondrial ornithine/citrulline carrier by SH reagents: effects on the transport activity and transition from carrier to pore-like function. Biochim Biophys Acta, 1611(1):123~130
Torres V J, Ivie S E, McClain M S, Cover T L. 2005. Functional properties of the p33 and p55 domains of the Helicobacter pylori vacuolating cytotoxin[. The Journal of Biological chemistry, 280(22):21107~21114
Torres V J, van Compernolle S E, Sundrud M S, Untmaz D, Cover T L. 2007. Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. Immunology, 179 (8): 5433~5440
Tsujimoto Y, Shimizu S. 2002. The voltage-dependent anion channel:an essential player in apoptosis. Biochimie, 84(2):187~193
Tsutsumi R, Higashi H, Higuchi M, Okada M, Hatakeyama M. 2003. Attenuation of Helicobacter pylori CagA x Shp-2 signaling by interaction between CagA and C-terminal Srckinase. Journal of Biological Chemistry, 278(6): 3664~3670
Tsutsumi R, Takahashi A, Azuma T, Higashi H, Hatakeyama M. 2006. Focal adhesion kinase is a substrate and downstream effector of Shp-2 complexed with Helicobacter pylori CagA. Molecular and Cellular Biology, 26(1): 261~276
Tummuru M K, Sharma S A, Blaser M J.1995.Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Molecular Microbiology, 18(5):867~876
van Doorn L J, Figueiredo C, Sanna R, Pena S, Midolo P, Ng E K-W, Atherton J C, Blaser M J, Quint W G. 1998. Expanding allelic diversity of Helicobacter pylori vacA. Journal of Clinical Microbiology, 36(9):2597~2603
Vander M G, Li X X, Gottleib E, Hill Blake R, Thompson C B, Colombini M. 2001. Bcl-xL promotes the open configuration of the voltage-dependent anion channel and metabolite passage throughthe outer mitochondrial membrane. Journal of Biological Chemistry, 276(22):19414~19419
Verrier F, Deniaud A, LeBras M, Metivier D, Kroemer G, Mignotte B,J an G, Bremer C. 2004. Dynamic evolution of the adenine nucleotide translocase interactome during chemotherapy-induced apoptosis.Oncogene, 23(6):8049~8064
Viala J, Chaput C, Boneca I G, Cardona A, Girardin S E, Moran A P, Athman R, Memet S, Huerre M R, Coyle A J, DiStefano P S, Sansonetti P J, Labigne A, Bertin J, Philpott D J, Ferrero R L. 2004. NodI responds to peptidoglycan delivered by the Helicobacte pylori cag pathogenicity island. Nature Immunology, 5(11):1166~1174
Vieira H L, Belzacq A S, Haouzi D,Bernassola F, Cohen I, Jacotot E, Ferri K F, El Hamel C, Bartle L M, Melino G, Brenner C, Goldmacher V, Krormer G. 2001. The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene, 20(32): 4305~4316
Vieira H L, Haouzi D, El Hamel C, Jacotot E, Belzacq A S, Brenner C, Kroemer G. 2000. Permeabilization of the mitochondrial inner membrane during apoptosis: impact of the adenine nucleotide translocator. Cell Death and Differentiation, 7(12):1146~1154
Vinion-Dubiel A D, McClain M S, Czajkowsky D M, Iwamoto H, Ye D, Cao P,Schraw W,Szabo G,Blanke S R, Shao Z, Cover T L.. 1999. A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibitis VacA-induced cell vacuolation. J Biol. Chem, 274(53): 37736~37742
Vyssokikh M Y, Katz A, Rueck A, Wuensch C, Dorner A, Zorov D B, Brdiczka D. 2001. Adenine nucleotide translocator isoforms 1 and 2 are differently distributed in the mitochondrial inner membrane and have distinct affinities to cyclophilin D. Biochemical Journal, 358(2):349~58
Walther T, Tsch?pe C, Sterner-Kock A, Westermann D, Heringer-Walther S, Riad A, Nikolic A, Wang Y, Ebermann L, Siems W-E, Bader M, Shakibaei M, Schultheiss H P, Dorner A. 2007. Accelerated mitochondrial adenosinediphosphate /adenosinetriphosphate transport improves hypertension-induced heart disease. Circulation, 115 (3):333~344
Wang H J, Wang W C. 2000. Expression and binding analysis of GST-vacA fusions reveals that the C-terminal approximately 100-residue segment of exotoxin is crucial for binding in HeLa cells. Biochem. Biophys.Res. Commun,278(2):449~454
Wang Y, Ebermann L, Sterner-Kock A, Wika S, Schultheiss H-P, Dorner A, Walther T. 2009. Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice. Exprimental Physiology, 94 (2): 220~227
Weeber E J, Levy M, Sampson M J, Anflous K, Armstrong D L, Brown S F, Sweatt J D, Craigen W J. 2002. The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity. Journal of Biological Chemistry, 277(21): 18891~18897
Wen Sicheng, Steven F M.2009.Helicobacter pylori virulence factors in gastric carcinogenesis.Cancer Letters, 282(1):1~8
Whiihite D C, Ye D, Blanke S R. 2002. Fluorescence resonance energy transfer microscopy of the Helicobacter pylori vacuolationg cytotoxin within mammalian cells.Infection and Immunity, 70(7): 3824~3832
Wieckowski M R, Szabadkai G, Wasilewski M, Pinton P, Duszynski J, Rizzuto R. 2006.
Overexpression of adenine nucleotide translocase reduces Ca2+ signal transmission between the ER and mitochondria. Biochemical and Biophysical Research Communications, 348(2):393~399
Willhite D C, Blanke S R. 2004. Helicobacter pylori vacuolating cytotoxin enters cells,localizes to the mitochondrial,and induces mitochondrial membrane permeability changes correlated to toxin channel activity.Cellular Microbiology,6(2):143~154
Willhite D C, Cover T L, Blanke S R. 2003. Cellular vacuolation and mitochondrial cytochrome c release are independent outcomes of Helicobacter pylori vacuolating cytotoxin activity that are each dependent on membrane channel formation.Journal of Biological Chemistry, 278(48):48204~48209
Windle H J, Fox A, Ni Eidhin D, Kelleher D. 2000. The thioredoxin system of Helicobacter pylori. Biological Chemistry, 275(7):5081~5089
Woodfield K, Ruck A, Brdiczka D, Halestrap A P. 1998. Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochemical Journal, 336(2):287~290
Xia H H, Talley N J.2001. Apotosis in gastric epithelium induced by Helicobacter pylori infectio:implications in gastric carcinogensis.America Journal of Gastroenterology,96(1):16~26
Ning X H,Zhang J, Liu J, Ye Y, Chen S H, From A H, Bache R J, Portman M A. 2000. Signaling and expression for mitechondrial membrane proteins during left ventricular re-modeling and contractile failure after myocardial infarction. Journal of American College of Cardiology, 36(1):282~287
Yahiro K, Niidome T, Hatakeyama T, Aoyagi H, Kurazono H, Padilla P I, Wada A, Hirayama T. 1997. Helicobacter pylori vacuolating cytotoxin binds to the 140kDa protein in human gastric cancer cell lines AZ-521 and AGS. Biochemical and Biophysical Research Communications, 238(2):629~632
Yahiro K, Wada A, Nakayame M, Kimura T, Ogushi K, Niidome T, Aoyagi H, Yoshio K, Yonezawa K, Moss J, Hirayama T. 2003. Protein-tyrosine Phosphataseα,RPTPα,Is a Helicobacter pylori VacA Receptor. Journal of Biological Chemistry, 278(3):19183~19189
Yamaoka Y, Kudo T, Lu H, et al.2004.Role of interferonstimulated responsive element-like element in interleu- kin-8 promoter in Helicobacter pylori infection.Gastroenterology, 126(4): 1030~1043
Yamaoka Y, Kwon D H, Graham D Y. 2000. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proceedings of the National Academy of Sciences of the United States of America, 97(13):7533~7538
Yamasaki E, Wada A, Kumatori A, Nakagawa I, Funao J, Nakayama M, Hisatsume J, Kimura M, Moss J, Hirayama T. 2006. Helicobacter pylori vacuolating cytotoxin indeces activation of the proapototic proteins Bax and Bak,leading to cytochrome c release and cell death,independent of vacuolation. Journal of Biological Chemistry, 81(16):11250~11259
Ye D, Willhitr D C, Blanke S R.1999.Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating toxin.Journal of Biological Chemistry, 274(14):9277~9282
Zambon C F , Basso D, Navaglia F, Germano G, Gallo N, Milazzo M, Greco E, Fogar P, Mazza S, Di Mario F, Basso G, Rugge M, Plebani M. 2002. Helicobacter pylori virulence genes and host IL-1RN and IL-1βgenes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine, 18(5):242~251
Zamora M, Granell M, Mampel T, Vinas O. 2004. Adenine nucleotide translocase 3 (ANT3) overexpression induces apoptosis in cultured cells. FEBS Letters, 563(1):155~160
Zamzami N, Hirsch T, Dallaporta B, Petit P X, Kroemer G. 1997. Mitochondrial implication in accidental and programmed cell death:apoptosis and necrosis. Journal of Bioenergy Biomembrane, 29(2):185~193
Zamzami N, Susin S A, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G. 1996. Mitochondrial control of nuclear apoptosis. Journal of Experimental Medicine, 183(4): 1533~1544
Zanotti G, Papinutto E, Dundon W, Battistutta R, Seveso M, Del Giudice G, Rappuoli R, Montecucco C. 2002. Structure of the neutrophil-activationg protein from Helicobacter pylori. Journal of Molecular Biology, 323(1):125~130
Zeaiter Z, Cohen D, Musch A, Bagnoli F, Covacci A, Strin M. 2008. Analysis of detergent-resistant membranes of Helicobacter pylori infected gastric adenocarcinoma cells reveals a role for MARK2/Parlb in CagA-mediated disruption of cellular polarity. Cell Microbiology, 10(3):781~794
Zheng P Y, Jones N L.2003. Helicobacter pyori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO(coronin I) protein.Cell Microbiology, 5(1):25~40
Zoratti M, Szabo I. 1995. The mitochondrial permeability transition. Biochim Biophys Acta , 1241(2): 139~176
杜佳,邓华瑜. 2009.线粒体在细胞凋亡中的介导作用.医学教育探索, 8(3):345~348
郭颖燕,方平楚. 2003.幽门螺杆菌的vacA基因亚型及其致病性.宁夏医学杂志, 25(7):446~447
候鹏. 1999.上海人幽门螺杆菌基因表型与相关胃肠疾病.中华内科杂志, 38(11):38
胡伏莲. 2006.幽门螺杆菌感染诊疗指南.北京:人民卫生出版社,10~19
黄宜娥,姜志胜. 2008.线粒体通透性转换孔在缺血后处理中的作用和机制.生命的化学, 28(5):637~640
梁钧,袁志明,梁布锋. 2002.幽门螺杆菌基因组研究.生物化学与生物物理进展, 29(1):39~41
林妙端,佘菲菲. 2009.幽门螺杆菌毒力基因与胃癌的研究进展.福建医科大学学报, 42(3):275~278
吕琳,王丕龙. 2009.重组幽门螺杆菌疫苗的研究现状.重庆医学, 38(8):984~987
孟菁菁,黄大毛,唐发清. 2008.蛋白质与蛋白质相互作用的研究进展.国际病理科学与临床杂志, 28(6):471~476
商熊跃,李敬远,曾因明. 2007.线粒体通透性转运孔道模型的研究进展.国际麻醉学于复苏杂志, 28(2):154~157
沈方,沈倩,夏强. 2005.细胞凋亡与线粒体通透性转变孔的研究进展.浙江大学学报(医学版), 34(2):191~196
唐清,王琳琳. 2006.幽门螺杆菌空泡毒素的作用机制研究进展.广西医科大学学报, 23(1): 162~164
吴丽华. 2007.幽门螺杆菌与胃部疾病关系的研究进展.中国现代医药杂志, 9(11):137~140
徐肇敏,李运红,王亚东,王亚东,陈家范,王宁,张志宏. 1999.江苏省胃癌高发区幽门螺杆
菌感染与胃癌、基因突变之间的关系.中华消化杂志, 19(4):236
杨艺,邓长生,姚学军,刘汉燕,陈默. 2001.幽门螺杆菌对胃上皮细胞系列SGC-7901细胞生长的影响.中华消化杂志, 21(2):113
袁建平,赵蔚,杨贵珍,胡宝瑜,童善庆,郭晓奎. 2003.幽门螺杆菌VacA真核表达载体的构建及其诱导细胞空泡化和凋亡.中国微生态学杂志, 15(2):66~68
张春梅,李松涛,董海波,方耀宗,国冬梅,张蕾蕾. 2006.幽门螺杆菌黏附素的研究.检验医学教育, 13(2):46~48
张红欣,宋文刚,郑成超. 2007.幽门螺杆菌基因工程疫苗的研究进展.细胞与分子免疫学杂志, 23(12):1099~1101
张微,刘纯杰. 2008.幽门螺杆菌致胃癌发生机制.胃肠病学和肝病学杂志,17(3):177~181
赵凌杰,吴旭. 2001.幽门螺杆菌与慢性胃炎及胃癌的关系.华南国防医学杂志, 15(2):21~24
赵雩卿,钱家鸣. 2004.幽门螺杆菌空泡毒素研究进展.胃肠病学和肝病学杂志, 13(3):322~325
Abu-Hamad S, Sivan S, Shoshan-Barmatz V. 2006. The expression level of the voltage-dependent anion channel controls life and death of the cell. Proceedings of the National Academy of Science of USA, 103(15):5787~5792
Aebischer T, Walduch A, Schroeder J,Wehrens A,Chijioke O,Schreiber S,Meyer T F. 2008. A vaccine against Helicobacter pylori:Towards understanding the mechanism of protection. International Journal of Medical Microbiology, 298(1):161~168
Aepulceda A R, Tao H, Carloni E.2002. Screening of gene expression profiles in gastric epithelial cells induces by Helicobacter pylori using micrp array analysis. Alimentary pharmacology & Therapeutics, 16(suppl 2):145~157
AlcaláS, Klee M, Fernández J, Fleische A,Pimentel- Mui?os F X. 2008. A high-throughput screening for mammalian cell death effectors identifies the mitochondrial phosphate carrier as a regulator of cytochrome c release. Oncogene, 27(1):44~54
Ali M, Khan A A, Tiwari S K, Ahmed N, Rao L V, Habibullah C M. 2005. Association between Cag pathogenicity island in Helicobacter pylori isolates from pepticulcer gastric carcinoma and non-ulcer dyspepsia subjects with histological changes. World Journal of Gastroenteology, 11(43):6815~6822
Allen L A, Schlesinger L S, Kang B. 2000. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. Journal of Experimental Medicine, 191(1):115~128
Alm R A, Bina J, Andrews B M, Doig P, Hancock R E-W, Trust T J.2000. Comparative genomics of Helicobacter pylori:analysis of the outer membrane protein families. Infection and Immunity, 68(7):4155~4168
Alm R A, Ling L S,Moir D T, King B L, Brown E D, Doig P C, Smith D S, Noonan B, Guild B C, deJonge B L, Carmel G, Tummino P J, Caruso A, Uria-Nichelsen M, Mills D M, Ives C, Gibson R, Merberg D, Mills S D, Jiang Q, Taylor D E, Vovis G F, Trust T J.1999.Genomic sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori.Nature,397(6715):176~180
Amieva M R, EI-Omar E M.2008.Host-bacterial interactions in Helicobacter pylori infecton. Gasroenterology, 134(1):306~323
Amieva M R, Vogelmann R, Covacci A, Tompkins L S, Nelson W J, Falkow S. 2003. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science, 300(5624):1430~1434
Anderden-Nissen E, Smith K D, Strobe K L, Barrett S L, Cookson B T, Logan S M, Aderem A.2005.Evasion of Toll-like receptor 5 by flagellated bacteria.Proceedings of the National Academy of Sciences of the United States of America, 102(26):9247~9252
An?ous-Pharayra K, Cai Z J, Craigen W J. 2007. VDAC 1 serves as a mitochondrial binding site for hexokinase in oxidative muscles. Biochim Biophys Acta, 1767(2):136~142
Atherton J C, Cao P, Peek R M, Tummuru M K, Blaser M J, Cover T L. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem., 270(30):17771~17777
Atherton J C.2006.The pathogenesis of Helicobacter pylori-induced gastro-duodenal disease.Annual Review of Pathology, 1(2):63~96
Backert S, Selbach M. 2008. Role of typeⅣsecretion in Helicobacter pylori pathogenesis.Cell Microbiology, 10(8):1573~1581
Backstrom A, Lundberg C, Kersulyte D, Berg D E, Boren T, Arnqvist A.2004.Metastability of Helicobacter pylori bab adhesin genes and dynamics in Lewis b antigen binding.Proceedings of the National Academy of Sciences of the United States of America,101(48):16923~16928
Baines C P, Kaiser R A, Sheiko T, Craigen W J, Molkentin J D. 2007. Voltage-dependent anion channels are dispensable for mitoch- ondrial-dependent cell death. Nature Cell Biology, 9(5):550~555
Baines C P, Molkentin J D. 2009b. Adenine nucleotide translocase-1 induces cardiomyocyte deaththrough upregulation of the pro-apoptotic protein Bax. Journal of Molecular Cell Cardiology, 46 (6): 969~977
Baines C P, Kaiser R A, Purcell N H, Blair N S, Osinska H, Hambleton M A, Brunskill E W, Sayen M R, Gottlieb R A, Dorn G W, Robbins J, Molkentin J D. 2005. Loss of cyclophilin D reveals a critical role for mitocho- ndrial permeability transition in cell death. Nature, 434(7033):658~662
Baines C P. 2009. The molecular composition of the mitochondrial permeability transition pore. Journal of Molecular and Cellular Cardiology, 46(2):850~857
Baltrus D A, Amieva M R, Covacci A, Lowe T M, Merrell D S, Ottemann K M, Stein M, Salama N R, Guillemin K.2009.The complete genome sequence of Helicobacter pylori strain G27.Journal of Bacteriology,191(1):447~448
Basso D, Zambon C F, Letley D P, Stranges A, Marchet A, Rhead J L, Schiavon S, Guariso G, Ceroti M, Nitti D, Rugge M, Plebani M, Atherton J C. 2008. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology, 135(1):91~99
Basso E, Fante L, Fowlkes J, Petronilli V, Fortes M A, Bernardi P.2005. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. Journal of Biological Chemistry, 280(5):18558~18561
Beals I L, Grabree J E, Scunes D, Covacci A, Calam J.1996. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology, 8 (7):645~649
Belzacq A S, Jacotot E, Vieira H L, Mistro D, Granville D J, Xie Z, Reed J C, Kroemer G, Brenner C. 2001a. Apoptosis induction by the photosensitizer verteporfin: identification of mitochondrial adenine nucleotide translocator as a critical target. Cancer Research, 61(4):1260~1264
Belzacq A S, Hamel C Ei,Vieira H L, Cohen I, Haouzi D, Metivier D, Marchetti P, Brenner C, Kroemer G. 2001b. Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine,arsenite and CD437. Oncogene, 20 (52): 7579~7587
Belzacq A S, Vieira H L, Verrier F, Vandecasteele G, Cohen I, Prevost M C, Larquet E, Pariselli F, Petit P X, Kahn A, Rizzuto R, Brenner C, Kroemer G. 2003. Bcl-2 and Bax Modulate Adenine Nucleotide Translocase Activity. Cancer Research, 63(2):541~546
Belzacq A S, Vieira H L, Kroemerb G, Brenner C.2002.The adenine nucleotide translocator in apoptosis. Biochimie,84(2):167~176
Blaser M J, Atherton J C. 2004. Helicobacter pylori persistence: biology and disease. Journal of Clinical Investigation, 113(3):321~333
Blaser M J, Atherton J C.2004.Helicobacter pylori persistence:biology and disease.Clinical Investigation, 113(3):321~333
Boquet P, Ricci V, Galmiche A, Gauthier N C.2003.Gastric cell apoptosis and Helicobacter. pylori: has the main function of VacA finally been identified?.Trends in microbiology, 11(9):410~413
Boren T, Falk P, Roth K A, Larson G, Normark S.1993.Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science, 262(5141):1892~1895
Bossy-Wetzel E, Green D R. 1999. Apoptosis:checkpoint at the mitochondrial frontier. Mutation Research, 434(4):243~251
Boya P, Pauleau A L, Poncet D, Gonzalez-Polo R A, Zamzami N, Kroemer G. 2004. Viral proteinstargeting mitochondrial:controlling cell death. Biochimica et Biophysica Acta, 1659(8):178~189
Brandt S, Kwok T, Harting R, Konig W, Backert S. 2005. NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proceedings of the National Academy of Sciences of the United States of America, 102(26):9300~9305
Brandt S, Shafikhani S, Balachandran P. 2007. Use of a novel coinfection system reveals a role for Racl, H-Ras, and Crk II phosphorylation in Helicobacter pylori induced host cell actin cytoskeletal rearrangement. FEMS Immunology and Medical Microbiology, 50(2):190~205
Bras M L, Borgne-Sanchez A, Touat Z, El Dein O S, Deniaud A, Maillier E, Lecellier G, Reboullat D, Lemaire C, Kroemer G, Jacotot E, Brenner C. 2006. Chemosensitization by Knockdown of Adenine Nucleotide Translocase-2.Cancer Research, 66(18):9143~9152
Brdiczka D. 1991. Contact sites between mitochondrial envelope membranes. Structure and function in energy- and protein-transfer. Biochemical Biophysics. Acta, 1071(3):291~312
Brustovetsky N, Klingenberg M. 1996. Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. Biochemistry, 35(26):8483~8488
Cascales E, Christie P J.2003.The versatile bacterial typeⅣsecretion systems.Nature Reviews of Microbiology, 1(2):137~149
Censini S, Lange C, Xiang Z, Crabtree J E, Ghiara P, Borodovsky M, Rappuoli R, Covacci A.1996.cag,A pathogenicity island of Helicobacter pylori,encodes type I-specifuc and disease-associated virulence factors.Proceedings of the National Academy of Sciences of the United States of America,93(25):14648~14653
Ceu F, Wim G V Quint, Ricardo S, Erwin S, John P D, Qing X, Geraldine G M, Richard M P, Martin J B, van Doorm L J. 2000. Genetic organization and heterogeneity of the iceA locus of Helicobacter pylori.Gene, 246(1):59~68
Chauvin C, De Oliveira F, Ronot X, Mousseau M, Leverve X, Fontaine E. 2001. Rotenone inhibits the mitochondrial permeability transition-induced cell death in U937 and KB cells. Journal of Biological Chemistry, 276 (44): 41394~41398
Chen X J. 2002. Induction of an unregulated channel by mutations in adenine nucleotide translocase suggests an explanation for human ophthalmoplegia. Human Molecular Genetics, 16(11):1835~1843
Cho S J, Kang N S, Park S Y, Kim B O, Rhee D K, Pyo S. 2003. Induction of apotosis and expression of apotosis related genes in human epithelial carcinoma cells by Helicoabater pylori VacA toxin. Toxicon, 42(6):601~611
Christian P, Martin S, Roland R, et al.2001.Key importance of the Helicobacter pylori adherence factor Blood Group Antigen Binding Adhesin during chronic gastric inflammation.Cancer Research, 61 (5):1903~1909
Christie P J, Atmakuri K, Krishnamoorthy V, Jakubowski S, Cascales E.2005. Biogenesis, architecture,and function of bacterial typeⅣsecretion systems. Annual Review of Microbiology, 59(10):451~485
Clarke S J, McStay G P, Halestrap A P. 2002. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin D at a different site from cyclosporin A. Journal of Biological Chemistry, 277(38): 34793~34799
Clyne M, Dolan B, Reeves E P.2007.Bacterial factors that mediate colonization of the stomach andvirulence of Helicobacter pylori.FEMS Mictobiology Letters, 268(2):135~143
Colbeck J C, Hansen L M, Fong J M. 2006. Penotypic profile of the outer membrane proteins BabA and BabB in clinical isolates of Helicobacter pylori. Infection and. Immunity, 74(7):4375~4378
Correa P. 1988.A Human model of gastric carcinogenesis.Cancer Research, 48(13):3554~ 3560
Correa P. 1992.Human gastric carcinogenesis: A multistep and multifactorial process-First American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Research, 52 (24):6735~6740
Costantini P, Belzacq A S, Vieira H L, Larochette N, de Pablo M A, Zamzami N, Susin S A, Brenner C, Kroemer G. 2000. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene, 19(2):307~314
Covacci A, Telford J L, Del Giudice G, Parsonner J, Rappuoli R.1999.Helicobacter pylori virulence and genetic geography.Science, 284(5418):1328~1333
Cover T L, Blaser M J. 1992.Purification and characterization of the vacuolating toxin from Helicobacter pylori.Journal of Biological Chemistry, 267(15): 10570~10575
Cover T L, Hanson P I, Heuser J E. 1997. Acid-induced dissociation of VacA,the Helicobacter pylori vacuolating cytotoxin,reveals its pattern of assembly. Journal of Cell Biology, 138(4):759~769
Cover T L, Krishna U S, Israel D A, Peek R M. 2003. Induction of gastric epithelial cell apoptosis by Helicobacter pyori vacuolating cytotoxin. Cancer Research, 63(5):951~957
Cover T L, Tummuru M K, Cao P, Thompson S A, Blaser M J. 1994. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. Journal of Biological Chemistry, 269 (14):10566~10573
Crompton M, Virji S, Ward J M. 1998. Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. European Journal of Biochemistry, 258(2):729~735
Crompton M. 1999. The mitochondrial permeability transition pore and its role in cell death. Biochemical Journal, 341(2):233~249
Croxen M A, Sisson G, Melano R, Hoffman P S.2006.The Helicobacter pylori chemotaxin receptor TlpB(HP0103) is required for pH taxis and for colonization of the gastric mucosa. Bacteriology, 188 (7):2656~2665
Czajkowsky D M, Iwamoto H, Cover T L, Shao Z F. 1999. The vacuolating cytotoxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. Proceedings of the National Academy of Sciences of the United States of America, 96(5):2001~2006
de Bernard M, Arico B, Papini E, Rizzuto R, Grandi G, Rappuoli R, Montecucco C. 1997. Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol. Molecular Microbiology, 26(4):665~674
de Bernard M, Burroni D, Papini E, Rappuoli R, Telford J, Montecucco C. 1998. Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol. Infection and Immunity,66(12):6014~6016
de Bernard M, Moschioni M, Napolitani G, Rappuoli R, Montecucco C. 2000. The VacA toxin of Helicobacter pylori identifies a new intermediate idament-interacting protein. Journal of European Molecular Biology Organization, 19(1):48~56
de Macedo D V, Nepomuceno M E, Pereira-da-Silva L. 1993. Involvement of the ADP/ATP carrier in perme- abilization processes of the inner mitochondrial membrane. European Journal of Biochemistry, 215(3):595~600
Degli E M, Dive C. 2003. Mitochondrial membrane permeabilisation by Bax/Bak. Biochemical and Bioph ysical Research Communications,304(3):455~461
Del Arco A, Agudo M, Satrústegui J. 2000. Characterization of a second member of the subfamily of calcium-binding mitochondrial carriers expressed in human non-excitable tissues. Biochemical Journal, 345(3):725~732
Del Arco A, Satrústegui J. 1998. Molecular cloning of Aralar, a new member of the mitochondrial carrier superfamily that binds calcium and is present in human muscle and brain. Journal of Biological Chemistry, 273(36):23327~23334
Desagher S, Martinou J C. 2000. Mitochondral as the central control point of apoptosis. Trends in Cell Biology, 10(9):369~378
Deschauer M, Hudson G, Muller T, Taylor R W, Chinnery P F, Zierz S. 2005. A novel ANT1 gene mutation with probable germline mosaicism in autosomal dominant p rogressive external phthalmoplegia. Neuromuscular Disorders, 15(4):311~315
Di Lisa F, Canton M, MenabòR, Kaludercic N, Bernardi P. 2007. Mitochondria and cardioprotection. Heart Failure Reviews, 12(3-4):249~260
Di Lisa F, MenabòR, Canton M, Barile M, Bernardi P. 2001. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD + and is a causative event in the death of myocytes in postischemic reperfusion of the heart. Journal of Biological Chemistry, 276(4):2571~2575
Lee A. 1996. Therapeutic immunisation against Helicobacter infection. Gastroenterology, 110(6):914~915
Dolce A, Scarcia P, Iacopetta D, Palmieri F.2005. A fourth ADP /ATP carrier isoform in man:identification, bacterial exp ression, functional characterization and tissue distribution. FEBS Letters, 579 (3): 633~637
Donahue J P, Peek R M, Van Doorn L J, Thompson S A, Qing X, Blaser M J, Miller G G. 2000. Analysis of iceA1 transcription in Helicobacter pylori. Helicobacter, 5(1):1~12
D?rner A, Pauschinger M, Schwimmbeck P L, Kuhl U, Schultheiss H P. 2000. The shift in the myocardial adenine nucleotide translocator isoform expression pattern is ssociated with an enteroviral infection in the absence of an active T-cell dependent immune response in human inflammatory heart disease. Journal of the American College of Cardiology, 35(7):1778~1784
Dorner B G, Scheffold A, Rolph M S. 2002. MIP-1[alpha],MIP-1[beta],RANTES,and ATAC /lymphotactin function together with IFN-[gamma] as type 1 cytokines. Proceedings of the National Academy of Sciences of the United States of America, 99(9):6181~6186
Dundon W G, de Bernard M, Montecucco C. 2001. Virulence factors of Helicobacter pylori. International Journal of Medical Microbiology, 290(2):647~658
Dunn B E, Campbell G P, Perez G I, Blaser M J. 1990. Purification and characterization of urease from Helicobacter pylori. Journal Biological Chemistry, 265(16):9464~9469
Eaton K A, Morgan D R, Krakowka S.1992.Motility as a factor in the colonization of gnotobioticpiglets by Helicobacter pylori.Medical Microbiology, 37(2):123~127
El-Omar E M, Carrington M, Chow W H. 2000. Rabkin CS.Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature, 404(6776):398~402
Eva P P, Cecile D G, Richard K, Veronique T, Guy J M, Gerard B. 2003. Structure of mitochondrial ADP /ATP carrier in comp lex with carboxyatractyloside. Nature, 426(6962):39~44
Eva P P, Gérard B. 2004. Nucleotide exchange in mitochondria:insight at a molecular level. Current Opinion in Structural Biology, 14(4):420~425
Fan X J, Gunasena H, Cheng Z J, Espejo R, Crowe S E, Ernst P B, Reyes V E. 2000. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apotosis. Journal of Immunology,165(4):1918~1924
Ferlay J, Autier P,Boniol M, Heamue M, Colombet M, Boyle P. 2007. Estinates of the cancer incidence and mortality in Europe in 2006. Annals of Oncology,18(3):581~592
Ficher W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. 2001. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island:essential genes for CagA translocation in host cells and induction of interleukin-8. Molecular Mictobiology, 42(5): 1337~1348
Fields S, Song O. 1989. A novel genetic system to detect protein-protein interactions.Nature, 340 (6230):119~125
Fiore C, Trézéguet V, Le Saux A, Roux P, Schwimmer C, Dianoux A C, Noel F, Lauquin G J-M, Brandolin G, Vignais P V. 1998. The mitochondrial ADP/ATP carrier:structural, physiological and pathological aspects. Biochimie, 80(2):137~150
Florence Verrier, Aure′lien Deniaud, Morgane LeBras, Didier Me′tivier, Guido Kroemer, Bernard Mignotte, Gwenae Jan, Catherine Brenner. 2004. Dynamic evolution of the adenine nucleotide translocase interactome during chemotherapy-induced apoptosis.Oncogene,23:8049~8064
Fontaine E, Eriksson O, Ichas F, Bernardi P. 1998. Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation by electron ?ow through the respiratory chain complex I. Journal of Biological Chemistry, 273(20):12662~12668
Forsyth M H, Atherton J C, Blaser M J, Cover T L. 1998. Heterogenetity in levels of vacuolating cytotoxin gene (vacA) transcription among Helicobacter pylori strains. Infection and Immunity, 66(7):3088~3094
Galluzzi L, Aaronson S A, Abrams J, Alnemri E S, Andrews D W, Baehrecke E H, Bazan N G, Blagosklonny M V, Blomgren K, Borner C, Bredesen D E, Brenner C, Castedo M, Cidlowski J A, Ciechanover A, Cohen G M, Laurenzi V D, Maria R D, Deshmukh M, Dynlacht B D, El-Deiry W S, Flavell R A, Fulda S, Garrido C, Golstein P, Gougeon M L, Green D R, Gronemeyer H, Hajnoczky G, Hardwick J M, Hengartner M O, Ichijo H, Jaattela M, Kepp O, Kimchi A, Klionsky D J, Knight R A, Kornbluth S, Kumar S, Levin B, Kroemer G. 2009. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death and Differentiation, 16(4):1093~1107
Galluzzi L, Maiuri M C, Vitale I, Zischka H, Castedo M, Zitvogel L, Kroemer G. 2007. Cell death modalities: classification and pathophysiological implications. Cell Death and Differentiation, 14(7): 1237~1243
Galluzzi L, Morselli E, Kepp O, Vitale I, Rigoni A, Vacchelli E, Michaud M, Zischka H, Castedo M, Kroemer G. 2010. Mitochondrial gateways to cancer. Molecular Aspects of Medicine, 31(1):1~20.
Galmiche A, Rassow J, Doye A, Cagnol S, Chambard J C, Contamin S, V. de Thillot, Just I, Ricci V, Solcia E, Van Obberghen E, Boquet P. 2000. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. Embo. J. 19 (23) 6361~6370
Garc?′a N, Zazueta C, Pavo′n N, Chavez E. 2005. Agaric acid induces mitochondrial permeability transition through its interaction with the adenine nucleotide translocase:Its dependence on membrane fluidity. Mitochondrion, 4(4):272~281
Garcia N, Martinez-Abundis E, Pavon N, Correa F, Chavez E. 2007. Copper induces permeability transition through its interaction with the adenine nucleotide translocase. Cell Biology International, 31(9):893~899
Garner J A, Cover T L. 1996. Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells. Infection and Immunity,64(10):4197~4203
Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. 2003. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science, 301(5636):1099~1102
Glocher E, Lange C,Covacci A, Bereswill S, Kist M, Pahi H L. 1998. Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-κB activation. Infection Immunology, 66(5):2346~2348
Goldmacher V S, Bartle L M, Skaletskaya A, Dionne C A, Kedersha N L, Vatet C A, Han J W, Lutz R J, Watanabe S, McFarland E D, Kieff E D, Mocarski E S, Chittenden T. 1999. A cytomegalovirus-encoded mitochondrialocalized inhibitor of apoptosis structurally unrelated to Bcl-2. Proceedings of National Academy of Sciences of the USA, 96(22):12536~12541
Gomez L, Thibault H, Gharib A, Dumont J M, Vuagniaux G, Scalfaro P, Derumeaux G, Ovize M. 2007. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. American Journal of Physiology, 293(3):1654~1661
Goto S, Chuman H, Majima E, Terada H. 2002. How does the mitochondrial ADP /ATP carrier distinguish transportable ATP and ADP from untransportable AMP and GTP? Dynamic modeling of the recognition /translocation p rocess in the major substrate binding region. Biochim Biophys Acta, 1589(2):203~218
Graham B H, Waymire K G, Cottrell B, Trounce I A, MacGregor G R, Wallace D C. 1997. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nature Genetics, 16(3):226~234
Graham D Y, Malaty H M, Evans D G, Ecans D J, Klein P D, Adam E. 1991. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States: effect of age, race and socioeconomic status.Gastroenterology,100(6):1495~1501
Green D R, Kroemer G.2004.The pathophysiology of mitochondrial cell death.Science,305 (5684): 626~629
Green D R, Reed J C. 1998. Mitochondria and apoptosis. Scienc, 281(5381):1309~1312
Grimm S, Brdiczka D. 2007. The permeability transition pore in cell death. Apoptosis, 12(2): Gupta V R, Patel H K, Kostolansky S S, Ballivian R A, Eichberg J, Blanke S R. 2008.
Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA. PLOS Pathogens, 4(5):1~12
Halestrap A P, Clarke S J, Javadov S A. 2004. Mitochondrial permeability transition pore openingduring myocardial reperfusion—a target for cardioprotection. Cardiovascular Research, 61(3):372~385
Halestrap A P, Davidson A M. 1990. Inhibition of Ca2+-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochemistry, 268(8):153~160
Leung A W C, Halestrap A P. 2008. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochimica et Biophysica Acta,1777(7-8):946-952.
Halestrap A P, Woodfield K Y, Connern C P. 1997. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. Journal of Biological Chemistry, 272(6):3346~3354
Halestrap A, McStay G P, Clarke S J. 2002. The permeability transition pore complex:another view. Biochime, 84(2):153~166
Han S R, Schreiber H J, Bhakdi S, Loos M, Maeurer M J. 1998. VacA genotypes and genetic diversity in clinical isolates of Helicobacter pylori. Clinical Diagnosis Lab Immunology, 5(2):139~145
Hashimoto M, Majima E, Hatanaka T, Shinohara Y, Onishi M, Goto S, Terada H. 2000. Irreversible extrusion of the first loop facing thematrix of the bovine heartmitochondrialADP /ATP carrier by labeling the Cys56 residue with the SH-reagent methylmethanethiosulfonate. Journal of Biochemistry, 127(3):443~449
Hausenloy D J, Duchen M R, Yellon D M. 2003. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia–reperfusion injury. Cardiovascular Research, 60(3):617~625
Haworth R A, Hunter D R. 2000. Control of themitochondrial permeability transition pore by high-affinity ADP binding at the ADP/ATP translocase in permeabilized mitochondria. Journal of Bioenergetics and Biomembranes, 32(1):91~96
Held M, Engstrand L, Hansson L E, Bergstrom R, Wadstrom T, Nyren O. 2004. Is the association between Helicobacter pylori and gastric cancer confined to CagA positive strains. Helicobacter, 9(3):271~277
Hennig E E, Butruk E, Ostrowski J.2001.RACK1 protein interacts with Helicobacter pylori VacA cytotoxin:the yeast two-hybrid approach.Biochemical and Biophysical Research Communications, 289(1):103~110
Hennig E E, Godlewski M M, Butruk E, Osteowski J. 2005. Helicobacter pylori VacA cytotoxin interacts with fibronectin and alters HeLa cell adhesion and cytoskeletal organization in vitro. FEMS Immunology and Medical Microbiology, 44(1):143~150
Tsuge H, Tsurumura T, Utsunomiya H, Kise D, Kuzuhara T, Watanabe T, Fujiki H, Suganima M. 2009. Structural basis for the Helicobacter pylori carcinogenic TNF -α-inducing protein. Biochemical and Biophysical Research Communications, 388(2):193~198
Higashi H, Nakaya A, Tsutsumi R, Yokoyama K, Fujii Y, Ishikawa S, Higuchi M, Takahashi A, Kurashima Y, Teishikata Y, Tanaka S, Azuma T, Hatakeyama M. 2004. Helicobacter pylori CagA induced Ras-independeng morphogenetic response through Shp-2 recruitment and activation. Journal of Biological Chemistry, 279(17):17205~17216
Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M. 2002. Shp-2tyrosine phosphataseas an intracellular target of Helicobacter pylori CagA protein. Science, 295(5555):683~686
Hoda M, Malaty.2007.Epidemiology of Helicobacter pylori infection.Best Practice & Research:Clinical Gastroenterology,21(2):205~214
Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. 1998. Development of Helicobacter pylori-induced gastric caicinoma in Mongolian gerbils.Cancer Research, 58(19):4255~4259
Ikenoue T, Maeda S, Ogura K, Akanuma M, Mitsuno Y, Imai Y, Yoshida H, Shiratori Y, Omata M. 2001. Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clinical and Diagnostic Laboratory Immunology, 8(1):181~186
Ilver D, Arnqvist A, Ogren J, et al.1998.Helicobacter pylori adhesion binding fucosylated histo-blood group antigens revealed by retagging. Science, 279(5349):373~377
International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori:Views and Expert Opinions of an IARC Working Group on theEvaluation of Carcinogenic Risks to Humans.1994.Lyon France,IARC Press, 6:177~240
Ito Y, Azuma T, Ito S, Miyaji H, Yamazaki Y, Sato F, Kato T, Kohli Y, Kuriyama M. 1997. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. Journal of Clinical Microbiology, 35(7):1710~1714
Iwamoto H, Czajkowsky D M, Cover T L, Szabo G, Shao Z F. 1999. VacA from Helicobacter pylori a hexameric chloride channel. FEBS Letter, 450(1):101~104
Jacotot E, Ferri K F, Hamel C E, Brenner C, Druillennec S, Hoebeke J, Rutin P, Metivier D, Lenoir C, Geuskens M, Vieira H L, Loeffler M, Belzacq A S, Briand J P, Zamzami N, Edelman L, Xie Z H, Reed J C, Roques B P, Kroemer G. 2001. Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. Journal of Experiment Medicine,193(4):509~519
Jacotot E, Ravagnan L, Loeffler M, Ferri K F, Vieira H L A, Zamzami N, Costantini P, Druillennec S, Hoebeke J, Briand J P, Irinopoulou T, Daugas E, Susin S A, Cointe D, Xie Z H, Reed J C, Roques B P, Kroemer G. 2000. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Experimental Medicine, 191(1):33~46
Jan G, Belzacq A S, Haouzi D, Rouault A, Metivier D, Kroemer G, Brenner C. 2002. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death and Differentiation, 9(2):179~188
Jorge O, Carrion F D, Jorge A, Ciocca D R. 2003. Helicobacter pylori infection affects the expression of PCNA,p53,c-erbB-2 and Bcl-2 in the human gastric mucosa. Reviews Espanish Enferm Digestive, 95(2):97~104
Kimura M,Goto S, Wada A, Yahiro K, Niidome T, Hatakeyama T, Aoyagi H, Hirayama T, Kondo T. 1999. Vacuolating cytotoxin purified from Helicobacter pylori cause mitochondrial damage in human gastric cells. Microbial Pathogenesis,26(1):45~52
Kluck R M, Bossy-Wetzel E, Green D R, Newmeyer D D. 1997. The release of cytochrome c from Mitochondria:A primary site for Bcl-2 regulation of apoptosis. Science, 275(5303):1132~ 1136
Kokoszka J E, Waymire K G, Levy S E, Sligh J E, Cai J Y, Jones D P, MacGregor G R, Wallace DC. 2004. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature, 427(6973):461~465
Kroemer G, El-Deiry W S, Golstein P, Peter M E, Vaux D, Vandenabeele P, Zhivotovsky B, Blagosklonny M V, Malorni W, Knight R A, Piacentini M,Nagata S, Melino G. 2005. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death and Differentiation, 12(sup 2):1463~1467
Kroemer G, Galluzzi L,Brenner C. 2007. Mitochondrial membrane permeabilization in cell death. Physiology Reviews,2007,87(1):99–163.
Kuck D, Kolmerer B, Iking-Konert C, Krammer P H, Stremmel W, Rudi J. 2001. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS.Infection and Immunity,69 (8):5080~5087
Kudo T, Nurgalieva Z Z, Conner M E, Crawford S, Odenbreit S, Haas R, Graham D Y, Yamaoka Y. 2004. Correlation between Helicobacter pylori OipA protein expression and OipA gene switch status. Journal of Clinical Microbiology, 42 (5): 2279~2281
Kuo C H, Wang W C. 2003. Binding and internalization of Helicobacter pylori VacA via cellular lipid rafts in epithelial cells. Biochemical and Biophysical Research Communications, 303(2):640~644
Kusters J G, van Vliet A H, Kuipers E J.2006.Pathogenesis of Helicobacter pylori infecton. Clinical Microbiology Reviews, 19(3):449~490
Kuzuhara T, Suganuma M, Kurusu M, Fujiki H. 2007. Helicobacter pylori-secreting protein Tipa is a potent inducer of chemokine gene expressions in stomach cancer cells. Cancer Research Clinical Oncology, 133(5):287~296
Kuzuhara T, Suganuma M, Oka K,Fujiki H. 2007. DNA-binding activity of TNF-a inducing protein from Helicobacter pylori. Biochemical and Biophysical Research Communications, 362(4):805~810
Lanzavecchia S, Bellon P L, Lupetti P, Dallai R, Rappuoli R, Telford J L. 1998. Three-dimensional reconstruction of metal replicas of the Helicobacter pylori vacuolating cytotoxin. Journal of Structural Biology, 121(1):9~18
Larche J, Lancel S, Hassoun S M, Favory R, Decoster B, Marchetti P, Chopin C, Neviere R. 2006.
Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality. Journal of American College of Cardiology, 48(2):377~385
Lee K M, Lee D S, Yang J M, Ahn B M, Lee E H, Yoo J Y, Chung I S, Sun H S, Park D H. 2003.
Effect of Helicobacter pylori on gastric epithelial cell kinetics and expression of apotosis-related proteins in gastric carcinogenesis. Korean Journal of Gastroenterol,42(1):12~19
Letley D P, Lastovica A, Louw J A, Hawkey C J, Atherton J C. 1999. Allelic diversity of the Helicobacter pyori vacuolating cytotoxin gene in South Africa:Rarity of the vacA s1a genotype and natural occurrence of an s2/m1 allele. Journal of Clinical Microbiology, 37(4):1203~1205
Leung A W, Varanyuwatana P, Halestrap A P. 2008. The mitochondrial phosphate carrier interacts with cyclophilin D andmay play a key role in the permeability transition. Journal of Biological Chemistry, 283(39):26312~26323
Leunk R D, Johnson P T, David B C, Kraft W G, Morgan D R. 1988. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med. Microbiol. 26 (2):93~99
Lu H, Hsu P I, Graham D Y, Yamaoka Y. 2005. Duodenal ulcer promoting gene of Helicobacterpylori. Gastroenterology, 128(4):833~848
Gomes L I, Rocha G A , Rocha A M C, Soares T F, Oliveira C A, Bittencourt P F S, Queiroz D M M. 2008. Lack of association between Helicobacter pylori infection with dupA-positive strains and gastroduodenal disease in Brizilian patiens. International Journal of Medical Microbiology, 298(3):223~230
Lupetti P, Heuser J E, ManeHi R, Massari P, Lanzavecchia S, Bellon P L, Dallai R, Eappuoli R, Telford J L. 1996. Oligomeric and subuit structure of the Helicobacter pylori vacuolating cytotoxin. Journal of Cell Biology, 133(4):801~807
Machida K, Hayashi Y, Osada H. 2002. A Novel Adenine Nucleotide Translocase Inhibitor, MT-21,Induces Cytochrome c Release by a Mitochondrial Permeability Transition- independent Mechanism. Journal of Biological Chemistry, 277(34):31243~31248
Maeda S,Yoshida H, Mitsuno Y, Hirata Y, Ogura K, Shiratori Y, Omata M. 2002. Analysis of apotosis and antiapotosis signaling pathways induced by Helicobacter pylori.Gut, 50(6): 771~778
Mahdavi J, Sonden B, Hurtig M, Olfat F O, Forsberg L, Roche N, Angstrom J, Larsson T, Teneberg S, Karlsson K A, Altraja S, Wadstrom T, Kersulyte D, Berg D E, Dubois A, Petersson C, Magnusson K E, Borberg T, Lindh F, Lundskog B, Arnqvist A, Hammarstrom L, Boren T. 2002. Helicobacter pylori SabA adhesin in persistent infection and chronic in?ammation. Science, 297(5581):573~578
Manente L, Perna A, Buommino E, Altucci L, Lucariello A, Citro G, Baldi A, Iaquinto G, Tufano M A, De Luca A. 2008. The Helicobacter pylori’s protein VacA has direct effects on the regulation of cell cycle and apoptosis in gastric epithelial cells. J. Cell Physiol,214 (3) 582~587
Manetti R, Masari P, Burroni D, de Bernard M, Marcini A, Olivieri R, Papini E, Montecucco C, Rappuoli R, Telford J L. 1995. Helicobacter pylori cytotoxin:importance of native conformation for induction of neutralizing antibodies. Infection and Immunity, 63(11): 4476~4480
Marchi U D, Campello S, SzabòI, Tombola F, Martinou J C, Zoratti M. 2004. Bax Does Not Directly Participate in the Ca2+-induced Permeability Transition of Isolated Mitochondria. Biological Chemistry, 279(5):37415~37422
Marina A H, Giedrius D, Martins L, Kalia A, Ilver D, Roche N, Vikstrom S, Sjostrom R, Linden S, Bachstrom A, Lundberg C, Arnqvist A, Mahdavi J, Nilsson U J, Velapatino B, Gilman R H, Gerhard M, Alarcon T, Lopez-Brea M, Nakazawa T, Fox J G, Correa P, Dominguez-Bello M G, Perez-Perez G I, Blaser M J, Normark S, Carlstedt I, Oscarson S, Teneberg S, Berg D E, Boren T. 2004. Functional adaptation of BabA, the Helicobacter pylori ABO Blood Group Antigen Binding Adhesin. Science,305(5683):519~522
Marshall B J,Warren J R.1984.Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceratiom.Laccet,1(8390):1311~1315
Marshall B J. 1994. Helicobacter pylori. American Journal of Gastroenterology, 89(2):116~128
Marzo I, Brenner C, Zamzami N, Susin S A, Beutner G, Brdiczka D, Remy R, Xie Z H, Reed J C, Kroemer G. 1998b. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. Journal of Experimental Medicine, 187(8): 1261~1271
Marzo I, Brenner C, Zamzami N, Jyrgensmeier J M, Susin S A, Vieira H L A, Prevost M C, Xie Z H, Matsuyama S, Reed J C, Kroemer G. 1998a. Bax and Adenine Nucleotide Translocator cooperate in the mitochondrial control of apoptosis. Science,281(5385):2027~2031
Massari P, Manetti R, Burroni D, Nuti S, Norais N, Rappuoli R, Telford J L. 1998. Binding of theHelicobacter pylori vacuolating cytotoxin to target cells. Infecton and Immunity, 66(8):3981~3984
Mattar R, Marques S B, Monteiro M S, dos Santos A F, Iriya K, Carrilho F J. 2007. Helicobacter pylori cag pathogenicity island genes:clinical relevance for peptic ulcer disease development in Brazil. Journal of Medical Microbiology, 56(1):9~14
Mayer B, Oberbauer R. 2003. Mitochondrial regulation of apoptosis. News in Physiological Sciences, 18(6):89~94
Mayer B, Oberbauer R. 2003. Mitochondrial regulation of apoptosis.News in Physiological Sciences,18(5):89~94
McClain M S, Schraw W, Ricci V, Boquet P, Cover T L. 2000. Acid activation of Helicobacter pylori vacuolating cytotocin(VacA) results in toxin internalization by eukalyotic cells. Molecular Microbiology, 7(2):433~442
McClain M S, Cao P, Iwamoto H, Vinion-Dubiel A D, Szabo G, Shao Z, Cover T L. 2001.
A12-amino-acid Segment,present in type s2 but not type s1 Helicobacter pylory VacA Proteins,Abolishes cytotoxin activity and alters membrane channel Formation. Journal of bacteriology, 183(22):6499~6508
McGee D J, Langford M L, Watson E L, Carter J E, Chen Y T, Ottemann K M. 2005. Colonization and inflammation deficiencies in Mongolian gerbils infected by Helicobacter pylori chemotaxis mutants. Infection and Immunity, 73 (3):1820~1827
McNamara D, EI-Omar E. 2008. Helicobacter pylori infection and the pathogensis of gastric cancer:A paradigm for host-bacterial interactions. Digestive and Liver Disease, 40(7): 504~509
Menaker R J, Ceponis P J, Jones N L.2004.Helicobacter pylori induces apotosis of Macrophages in association with alteration in the mitochondrial pathway.Infection and Immunity, 72(5):2889~2898
Merrell D S, Goodrich M L, Otto G, Tompkins L S, Falkow S. 2003. pH-regulated gene expression of the gastric pathogen Helicobacter pylori. Infection and Immunology, 71(6):3529~ 3539
Michetti P, Corthesy-Theulaz I, Davin C, et al. 1994. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology, 107(4):1002~1011
Minuro H, Suznki T, Tanaka J, Asahi M, Haas R, Sasakawa C. 2002. Grb2 is a key mediator of cagA protein activities. Molecular Cell, 10(4):745~755
Mireille B, Gerard B, Michel S, Gerard K. 1999. The mitochondria adenine nucleotide translocator from dictyostelium: functional characterization and DNA sequancing. European Journal of Biochemistry, 259(3):795~800
Miyamoto S, Murphy A N, Brown J H. 2008. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death and Differentiation, 15 (3):521~529
Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn S J. 1997. Murine CD4 T-cell response to Helicobacter infection:TH1 cells enhance gastritis and TH2 cell reduce bacterial load. Gastroenterology, 113(6):848~857
Mohammadi M, Oghalaie A, Mohajerani N, Massarrat S, Nasiri M, Bennedsen M, Colding H, Andersen L P. 2003. Prevalence of Helicobacter pylori vacuolating cytotoxin and its allelic mosaicism as a predictive marker for Iranian dyspeptic patients. Bulletin Society Pathological Exotique, 96(1):3~5
Mohammadi M, Redline R, Nedrud J, Nedrid J. 1996. Helicobacter specific cell mediated immune resposes display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in thestomach of mice. Journal of Immunology, 156(12):4729~4738
Molinari M, Galli C, Norais N, Telford J L, Rappuoli R, Luzio J P, Montecucco C. 1997. Vacuoles induced by Helicobacter pylori toxin contain both lateendosomal and lysosomal markers. Journal of Biological Chemistry, 272(40):25339~25344
Molinari M, Salio M, Galli C, Norais N, Rappuoli R, Lanzavecchia A, Montecucco C. 1998.
Selective inhibihton of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. Journal of Experimental Medicine, 187(1):135~140
Morbiato L, Tombola F, Campello S. 2001. Vacuolation induced by VacA toxin of Helicobacter pylori requires the intracellularaccumulation of membrane permeant bases,C1 and water. FEBS Letter, 508(3):479~483
Moss S F, Sordillo E M, Abdalla A M, Makarov V, Hanzely Z, Perez-Perez G I, Blaser M J, Holt P R. 2001. Increased gastric epithelial cell apoptosis associated with colonization with CagA+ Helicobacter pylori strains. Cancer Research, 61(4):1406~1411
Murphy E, Steenbergen C. 2008. Mechanisms underlying acute protection from cardiac ischemia–reperfusion injury. Physiological Reviews, 88(2):581~609
Mutata K N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek R M, Azuma T, Hatakeyama M. 2007. Helicobacter pylori CagA interacts with E-cadherin and deregulates theβ-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene, 26(32):4617~4626
Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T, Tsujimoto Y. 2005. CyclophilinD-dependentmitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature, 434(7033):652~658
Natio M, Yamazaki T, Tsutsumi R, Higashi H, Onoe K, Yamazaki S, Azuma T, Hatakeyama M. 2006.
Influence of EPIYA repeat polymorphism on the phosphorylation dependent biological activity of Helicobacter pylori CagA. Gastroenterology, 130(4):1181~1190
Neu B, Randlkofer P, Neubhofer M, Voland P, Mayerhofer A, Gerhard M, Schepp W, Prinz C. 2002.
Helicobacter pyori induces apoptosis of rat gastric parietal cells. American Journal of Physiology Gastrointestinal and Liver Physiology, 283(2):309~318
Notario B, Zamora M, Vinas O, Mampel T. 2003. All-trans-Retinoic Acid Binds to and Inhibits Adenine Nucleotide Translocase and induces Mitochondrial Permeability Transition. Molecular Pharmacology,63 (1):224~231
Odenbreit S. 2007. Adherence properties of Helicobacter pylori:impaction pathogenisis and adaptation to the host. International Journal of Medical Microbiology, 295(5):317~324
Oh J D, King-Backhed H, Giannakis M, Xu J, Fulton R S, Fulton L A, Cordum H S, Wang C Y, Elliott G, Edwards J, Mardis E R, Engstrand L G, Gordon J I. 2006. The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain:evolution during disease progression. Proceedings of the National Academy of Sciences of the United States of America, 103(26):9999~10004
Owen R J, Sharp S, Lawson A J, Durrani Z, Rijpkema S, Kidd M. 2003. Investigation of the biological relevance of Helicobacter pylori cage locus diversity,presence of CagA tyrosine phosphorylation motifs and vacuolating cytotoxin genotype on IL-8 induction in gastric epithelial cells. FEMS Immunology & Medical Microbiology, 36(3):135~140
Padilla P I, Wada A, Yahiro K, et al. 2000. Morphologic differentiation of HL-60 cells is associated with appearance of RPTPβand induction of Helicobacter pylori VacA sensitivity. Journal of Biological Chemisry, 275(3):15200~15206
Pagliaccia C, de Bernard M, Lupetti P, Ji X, Burroni D, Cover T L, Papini E, Rappuoli R, Telford J L, Reyrat J M. 1998. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc. Natl. Acad. Sci. USA ,95(17):10212~10217
Pai R, Cover T L, Tarnawski A S. 1999. Helicobacter pylori Vacuolating cytotoxin disorganizes the cytoskeletal architecture of gastric epithelial cells. Biochemical and Biophysical Research Communications, 262(7):245~250
Palmier F. 2004. The mitochondrial transporter family(SLC25):physiological and pathological implications. Pflügers Archiv European Journal of Physiology, 447(5):689~709
Papini E, de Bernard M, Milia E, Bugnoli M, Zerial M, Rappuoli R, Montecucco C. 1994. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc. Natl. Acad. Sci.USA ,91 (21):9720~9724
Papini E, Satin B, Bucci C, de Bernard M, Telford J L, Manetti R, Rappuoli R, Zerial M, Montecucco C. 1997. The small GTP binding protein rab7 is essential for cellular vacuolation induced by Helicobacter pylori cytotoxin. Journal of European Molecular Biology Organization, 16(1):15~24
Papini E, Satin B, Norais N, de Bernard M, Telford J L, Rappuoli R, Montecucco C. 1998. Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pyori cacuolating toxin. Journal of Clinical Investigation, 102 (4): 813~820
Papini E, Zoratti M, Cover T L. 2001. In search of the Helicobacter pylori VacA mechanism of action. Toxincon, 39(1):1757~1767
Papini E, Zoratti M, Cover T L. 2001. In search of the Helicobacter pylori VacA mechanism of action. Toxicon , 39(11):1757~1767
Parsonnet J.1993. Helicobacter pylori and gastric cancer. Gastroenterology Clinics North American, 22(1):89
Patel H K, Wiihite D C, Patel R M, Ye D, Williams C L, Torres E M, Marty K B, MacDonald R A, Blanke S R. 2002. Plasm membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin. Infectio and Immunity, 70(8):4112~ 4123
Pedersen P L. 2007. The cancer cell’s‘‘power plants”as promising therapeutic targets: an overview. Journal of Bioenergetics and Biomembrane, 39(1):1~12
Peek R M Jr, Thompson S A, Donahue J P, Tham K T, Atherton J C, Blaser M J, Miller G G. 1998.
Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proceedings of the Association of American Physicians , 110(6):531~544
Peek R M, Blaser M J.2002.Helicobacter pylori and gastrointestinal tract adenocarcinomas.Nature Reviews Cancer,2(1):28~37
Peek R M, Crabtree E.2006.Helicobacter pylori infection and gastric neoplasia.Journal of Pathology,208(2):233~234
Phadnis S H, IIver D, Janzon L, Normark S, Westblom T U. 1994. Pathological significance and molecular chatacterization of the vacuolating toxin gene of Helicobacter pylori. Infection and Immunity, 62(5):1557~1565
Piantadosi C A, Carraway M S, Suliman H B. 2006. Suliman. Carbon monoxide, oxidative stress, and mitochondrial permeability pore transition. Free Radical Biology and Medicine, 40(8): 1332~1339
Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung T T, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, Andre-Fouet X, Revel D, Kirkorian G, Monassier J P, Derumeaux G, Ovize M. 2008. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. New England Journal of Medicine, 359(5):473~481
Proenca J L, Lopes A I, Acrani G O, Russo R, Ribeiro M A, Fukuhara Y, da Silveira W D, Modena J L, de Oliveiea R B, Brocchi M. 2007. Association between Helicobacter pylori genotypes and gastric disorders in relation to the cag pathogenicity island. Diagnostic Microbiology and Infectious Disease, 59(1):7~16
Proenca-Modena J L, Acrani G O, Brocchi M.2009.Helicobacter pylori:phenotypes,genotypes and virulence genes.Future Microbiology, 4(2):223~240
Rain J C, Selig L, De Reuse H, Battaglia V, Reverdy C, Simon S, Lenzen G, Petel F, Wojcik J, Schachter V, Chemama Y, Labigne A, Legrain P. 2001. The protein-protein interaction map of Helocobacter pylori. Nature , 409(6817):211~215
Ramírez R A, Sánchez S R.2009.Helicobacter Pylori 25 years after (1983 -2008): epidemiology, microbiology,pathogenics,diagnostics and treatment.Revista de Gastroenterologia del Peru, 29(2):158~170
Reichert A S, Neupert W. 2004. Mitochondriomics or what makes us breathe. Trends in Genetics, 20(11):555~562
Reyrat J M, Lanzavecchia S, Lupetti P, de Bernard M, Pagliaccia C, Pelicic V, Charrel M, Ulivieri C, Norais N, Ji X H, Cabiaux V, Papini E, Rappuoli R, Telford J L. 1999. 3 D imaging of the 58 kD cell binding subunit of the Helicobacter pylori cytotoxin. Journal of Molecular Biology, 290(2):459~470
Ricci V, Sommi P, Fiocca R, Romano M, Solcia E, Ventura U. 1997. Helicobacter pylori vacuolating toxin accumulates with in the endosomal-vacuolar compartment of cultured gastric cells and potentiates the vacuolating activity ammonia. Journal of Pathology,183(4):453~459
Robinson K.2007.The inflammatory and immune response to Helicobacter pylori infection.Best Practice & Research Clinical Gastroenterology, 21(2):237~259
Roche N, Ilver D, Angstrom J, Barone S, Telford J L, Tenberg S. 2007. Human gastric glycosphingolipids recognized by Helicobacter pylori vacuolating cytotoxin VacA. Microbes and Infection, 9(5):605~614
Rostovtseva T K, Tan W, Colombini M. 2005. On the role of VDAC in apoptosis: fact and fiction. Journal of Bioenergetics and Biomembranes, 37(3):129~142
Rück A, Dolder M, Wallimann T, Brdiczka D. 1998. Reconstituted adenine nucleotide translocase forms a channel for small molecules comparable to the mitochondrial permeability transition pore. FEBS Letters, 426(1):97~101
Saadat I, Higashi H, Obuse C, et al. 2007. Helicobacter pylori CagA targets PARI/MARK kinase to disrupt epithelial cell polarity. Nature, 447(7124):330~333
Sachs G, Weeks D L, Wen Y, Marcus E A, Scott D R. 2005. Acid acclimation by Helicobacter pylori. Physiology (Bethesda), 20(12):429~438
Schinzel A C, Takeuchi O, Huang Z H, Fisher J K, Zhou Z P, Rubens J, Hetz C, Danial N N, Moskowitz M A, Korsmeyer S J. 2005. Cyclophilin D is a component of mitochondrial permeabilitytransition and mediates neuronal cell death after focal cerebral ischemia. Proceeding of National Academy of Sciences of USA, 102(34):12005~12010
Schmitt W, Haas R. 1994. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin:structural similarities with the IgA protease type of exported protein. Molecular Microbiology, 12(2): 307~319
Schraw W, Li Y, McClain M S, van der Goot F, Cover T L. 2002. Association of Helicobacter pylori vacuolating toxin(VacA) with lipid rafts. Journal of Biological Chemistry, 277(37):34642~34650
Schultheiss H P, Schulze K, Kuhl U, Ulrich G, Klingenberg M. 1986. The ADP/ATP carrier as a mitochondrial auto-antigen--facts and perspectives. Annals of the New York Academy of Sciences, 488(7):44~64
Sebastian R D, Bruno G, Ling L, Hans F. 2005. Identification of two new Helicobacter pylori surface proteins involved in attachment to epithelial cell lines. Journal of Medical Microbiology, 54(5):427~434
Selbach M, Moese S, Hurwitz R, Hauck C R, Meyer T F, Backert S. 2003. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. European Molecular Biology Organizition Journal, 22(3):515~528
Seto K, Hayashi-Kuwabara Y, Yoneta T, Suda H, Tamaki H. 1998. Vacuolation induced by cytotoxin from Helicobacter pylori is mediated by receptor in Hela cells. FEBS Letter, 431(3):347~350
Shibata W, Hirata Y, Maeda S, Ogura K, Ohmae T, Yanai A, Mitsuno Y, Okamoto M, Yoshida H, Kawabe T, Omata M. 2006. CagA protein secreted by the intact typeⅣsecretion system leads to gastric epithelial inflammation in the Mobgolian gerbil model. Journal of Pathology, 210(3): 306~314
Shimizu S, Matsuoka Y, Shinohara Y, Yoneda Y, Tsujimoto Y. 2001. Essential role of voltage-dependent anion channel in vario- us forms of apoptosis in mammalian cells. The Journal of Cell Biology, 152(2):237~250
Shimizu S, Narita M,Tsujimoto. 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 399(6735):483~487
Solnick J V, Hansen L M, Salama N R, Boonjakuakul J K, Syvanen M. 2004. Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques. Proceedings of the National Academy of Sciences of the United States of America, 101(7):2106~2111
Stephane G, Christelle B B, Micheline W L. 1998. Expression of human ANT2 gene in highly p roliferative cells: GRBOX, a new transcrip tional element,is involved in the regulation of glycoloytic ATP into mitochondria. Molecular Biology, 281(3):409~418
Stingl K, De Reuse H. 2005.Staying alive overdosed:how does Helicobacter pylori control urease activity?.International Journal of Medical Microbiology, 295(5):307~315
Strobel S, Bereswill S, Balig P, Allgaier P, Sonntag H G, Kist M. 1998. Identification and analysis of a new VacA genotype variant of Helicobacter pylori in different patient groups in Germany. Journal of Clinical Microbiology, 36 (5):1285~1289
Suganuma M, Kurusu M, Suzuki K, Nishizono A, Murakami K, Fujioka T, Fujuki H. 2005. New tumor necrosis factor-a-inducing protein released from Helicobacter pylori for gastric cancer progression. Cancer Research Clinical Oncology, 131(5):305~313
Suganuma M, Kuzuhara T, Yamaguchi K, Fujiki H. 2006. Carcinogenic role of tumor necrosis factor-a inducing protein of Helicobacter pylori in human stomach. Biochemistry and Molecular. Biology,39, (1): 1~8
Suganuma M, Yamaguchi K, OnoY, Matsumoto H, Hayashi T, Ogawa T, Imai K, Kuzuhara T, Nishizono A, Fujiki H. 2008. TNF-α-inducing protein, a carcinogenic factor secreted from Helicobacter pylori, enters gastric cancer cells. International Journal of Cancer, 123(1): 117~122
Sun L, Shukair S, Naik T J, Moazed F, Ardehali H. 2008. Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Molecular and Cell Biology, 28(3):1007~1017
Sundrud M S, Torres V J, Unutmaz D, Cover T L. 2004. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proceedings of National Academyof Sciences of the USA, 101(20):7727~7732
Supajatura V, Ushio H, Wada A, Yahiro K, Okumura K, Ogawa H, Hirayama T, Ra C. 2002. VacA,a vacuolating cytotoxin of Helicobacter pylori,directly activates mast cells for migration and production of proinflammatory cytokines. Immunogy, 168(6):2603~2607
Suzuki M, Mimuro H, Suzuki T, Park M, Yamamoto T, Sasakawa C. 2005. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. Journal of Experimental Medicine, 202(9):1235~1247
Szabo I, Brutsche S, Tombola F, Moschioni M, Satin B, Telford J L, Rappuoli R, Montecucc C, Papini E, Zoratti M. 1999. Formation of anion selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. Journal of European Molecular Biology Organization, 18(20):5517~5527
SzabóI, De Pinto V, ZorattiM. 1993b. Themitochondrial permeability transition poremay comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitoch- ondrial megachannel. FEBS Letters, 330(2): 206~210
SzabóI, Zoratti M. 1993a. The mitochondrial permeability transition pore may comprise VDACmolecules. I. Binary structure and voltage dependence of the pore. FEBS Letters, 330(2): 201~105
Szaleczky E, Pronai L, Molnar B, Berczi L, Feher J, Tulassay Z. 2000. Increased cell proliferation in chronic Helicobacter pylori positive gastritis and gastric carcinoma correlation between immunohistochemistry and TV image cytometry. Analytical Cellular Pathology, 20(2):131~139
Talebkhan Y, Mohammadi M. 2003. Vacuolating cytotoxin of Helicobacter pylori. Iranian Journal of Biotechnology, 1(2):73~81
Tammer I, Brandt S, Harting R, Konig W, Backert S. 2007. Activation of Abl by Helicobacrer pylori:a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology, 132(4):1309~1319
Tan W, Colombini M. 2007. VDAC closure increases calcium ion ?ux. Biochimical Biophysical Acta, 1768(10):2510~2515
Telford J L, Ghiara P, Dell’Ocro M, Comanducci M, Burroni D, Bugnili M, Tecce M F, Cenisini S, Covacci A, Xiang Z. 1994. Gene structure of the Helicobater pylori cytotoxin and evidence of its key role in gastric disease. Journal of Experiment Medicine, 179(5):1653~1658
Tikhonova I M, Andreyev A Yu, Antonenko Yu N, Kaulen A D, Komrakov A Y, Skulachev V P. 1994. Ion permeability induced in artificial membranes by the ATP/ADP Antiporter. FEBS Letters, 337(3):231~234
Tomb J E, White O, Kerlavage A R, Clayton R A, Sutton G G, Fleischmann R D, Ketchum K A, Klenk H P, Gill S, Dougherty B A, Nelson K, Quachenbush J, Zhou L X, Kirkness E F, Peterson S, Loftys B, Richardson D, Dodson R, Khalak H G, Glodek A< McKenney K, Fitzegerald L M, Lee N, Adams M D, Hichey E K, Berg D E, Gocayne J D, Utterback T R, Peterson J D, Kelley J M, Cotton M D, Weidman J M, Fujii C, Bowman C, Watthey L, Wallin E, Hayes W S, Borodovsky M, Karp P D, Smith H O, Fraser C M, Venter J C. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature,388(6642):539~547
Tombola F, Carlesso C, Szabo I, de Bernard M. 1999. Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers:possible implications for the mechanism of cellular vacuolation. Biophysical Journal, 76(3):1401~1409
Tombola F, Morbiato L, del Giudice G, Rappuoli R, Zoratti M, Papini E. 2001. The Helicobacter pyori VacA toxin is a urea permease that promotes urea diffusion across epithelia. Journal of Clinical Investigation, 108(5):929~937
Tosi T, Cioci G, Jouravleva K, Dian C, Terradot L. 2009. Structure of the tumor necrosis factorαindecing protein Tipα:A novel virulence factor from Helicobacter pylori. FEBS Letters, 583(10):1581~1585
Tonazzi A, Indiveri C. 2003. Chemical modification of the mitochondrial ornithine/citrulline carrier by SH reagents: effects on the transport activity and transition from carrier to pore-like function. Biochim Biophys Acta, 1611(1):123~130
Torres V J, Ivie S E, McClain M S, Cover T L. 2005. Functional properties of the p33 and p55 domains of the Helicobacter pylori vacuolating cytotoxin[. The Journal of Biological chemistry, 280(22):21107~21114
Torres V J, van Compernolle S E, Sundrud M S, Untmaz D, Cover T L. 2007. Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. Immunology, 179 (8): 5433~5440
Tsujimoto Y, Shimizu S. 2002. The voltage-dependent anion channel:an essential player in apoptosis. Biochimie, 84(2):187~193
Tsutsumi R, Higashi H, Higuchi M, Okada M, Hatakeyama M. 2003. Attenuation of Helicobacter pylori CagA x Shp-2 signaling by interaction between CagA and C-terminal Srckinase. Journal of Biological Chemistry, 278(6): 3664~3670
Tsutsumi R, Takahashi A, Azuma T, Higashi H, Hatakeyama M. 2006. Focal adhesion kinase is a substrate and downstream effector of Shp-2 complexed with Helicobacter pylori CagA. Molecular and Cellular Biology, 26(1): 261~276
Tummuru M K, Sharma S A, Blaser M J.1995.Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Molecular Microbiology, 18(5):867~876
van Doorn L J, Figueiredo C, Sanna R, Pena S, Midolo P, Ng E K-W, Atherton J C, Blaser M J, Quint W G. 1998. Expanding allelic diversity of Helicobacter pylori vacA. Journal of Clinical Microbiology, 36(9):2597~2603
Vander M G, Li X X, Gottleib E, Hill Blake R, Thompson C B, Colombini M. 2001. Bcl-xL promotes the open configuration of the voltage-dependent anion channel and metabolite passage throughthe outer mitochondrial membrane. Journal of Biological Chemistry, 276(22):19414~19419
Verrier F, Deniaud A, LeBras M, Metivier D, Kroemer G, Mignotte B,J an G, Bremer C. 2004. Dynamic evolution of the adenine nucleotide translocase interactome during chemotherapy-induced apoptosis.Oncogene, 23(6):8049~8064
Viala J, Chaput C, Boneca I G, Cardona A, Girardin S E, Moran A P, Athman R, Memet S, Huerre M R, Coyle A J, DiStefano P S, Sansonetti P J, Labigne A, Bertin J, Philpott D J, Ferrero R L. 2004. NodI responds to peptidoglycan delivered by the Helicobacte pylori cag pathogenicity island. Nature Immunology, 5(11):1166~1174
Vieira H L, Belzacq A S, Haouzi D,Bernassola F, Cohen I, Jacotot E, Ferri K F, El Hamel C, Bartle L M, Melino G, Brenner C, Goldmacher V, Krormer G. 2001. The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene, 20(32): 4305~4316
Vieira H L, Haouzi D, El Hamel C, Jacotot E, Belzacq A S, Brenner C, Kroemer G. 2000. Permeabilization of the mitochondrial inner membrane during apoptosis: impact of the adenine nucleotide translocator. Cell Death and Differentiation, 7(12):1146~1154
Vinion-Dubiel A D, McClain M S, Czajkowsky D M, Iwamoto H, Ye D, Cao P,Schraw W,Szabo G,Blanke S R, Shao Z, Cover T L.. 1999. A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibitis VacA-induced cell vacuolation. J Biol. Chem, 274(53): 37736~37742
Vyssokikh M Y, Katz A, Rueck A, Wuensch C, Dorner A, Zorov D B, Brdiczka D. 2001. Adenine nucleotide translocator isoforms 1 and 2 are differently distributed in the mitochondrial inner membrane and have distinct affinities to cyclophilin D. Biochemical Journal, 358(2):349~58
Walther T, Tsch?pe C, Sterner-Kock A, Westermann D, Heringer-Walther S, Riad A, Nikolic A, Wang Y, Ebermann L, Siems W-E, Bader M, Shakibaei M, Schultheiss H P, Dorner A. 2007. Accelerated mitochondrial adenosinediphosphate /adenosinetriphosphate transport improves hypertension-induced heart disease. Circulation, 115 (3):333~344
Wang H J, Wang W C. 2000. Expression and binding analysis of GST-vacA fusions reveals that the C-terminal approximately 100-residue segment of exotoxin is crucial for binding in HeLa cells. Biochem. Biophys.Res. Commun,278(2):449~454
Wang Y, Ebermann L, Sterner-Kock A, Wika S, Schultheiss H-P, Dorner A, Walther T. 2009. Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice. Exprimental Physiology, 94 (2): 220~227
Weeber E J, Levy M, Sampson M J, Anflous K, Armstrong D L, Brown S F, Sweatt J D, Craigen W J. 2002. The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity. Journal of Biological Chemistry, 277(21): 18891~18897
Wen Sicheng, Steven F M.2009.Helicobacter pylori virulence factors in gastric carcinogenesis.Cancer Letters, 282(1):1~8
Whiihite D C, Ye D, Blanke S R. 2002. Fluorescence resonance energy transfer microscopy of the Helicobacter pylori vacuolationg cytotoxin within mammalian cells.Infection and Immunity, 70(7): 3824~3832
Wieckowski M R, Szabadkai G, Wasilewski M, Pinton P, Duszynski J, Rizzuto R. 2006.
Overexpression of adenine nucleotide translocase reduces Ca2+ signal transmission between the ER and mitochondria. Biochemical and Biophysical Research Communications, 348(2):393~399
Willhite D C, Blanke S R. 2004. Helicobacter pylori vacuolating cytotoxin enters cells,localizes to the mitochondrial,and induces mitochondrial membrane permeability changes correlated to toxin channel activity.Cellular Microbiology,6(2):143~154
Willhite D C, Cover T L, Blanke S R. 2003. Cellular vacuolation and mitochondrial cytochrome c release are independent outcomes of Helicobacter pylori vacuolating cytotoxin activity that are each dependent on membrane channel formation.Journal of Biological Chemistry, 278(48):48204~48209
Windle H J, Fox A, Ni Eidhin D, Kelleher D. 2000. The thioredoxin system of Helicobacter pylori. Biological Chemistry, 275(7):5081~5089
Woodfield K, Ruck A, Brdiczka D, Halestrap A P. 1998. Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochemical Journal, 336(2):287~290
Xia H H, Talley N J.2001. Apotosis in gastric epithelium induced by Helicobacter pylori infectio:implications in gastric carcinogensis.America Journal of Gastroenterology,96(1):16~26
Ning X H,Zhang J, Liu J, Ye Y, Chen S H, From A H, Bache R J, Portman M A. 2000. Signaling and expression for mitechondrial membrane proteins during left ventricular re-modeling and contractile failure after myocardial infarction. Journal of American College of Cardiology, 36(1):282~287
Yahiro K, Niidome T, Hatakeyama T, Aoyagi H, Kurazono H, Padilla P I, Wada A, Hirayama T. 1997. Helicobacter pylori vacuolating cytotoxin binds to the 140kDa protein in human gastric cancer cell lines AZ-521 and AGS. Biochemical and Biophysical Research Communications, 238(2):629~632
Yahiro K, Wada A, Nakayame M, Kimura T, Ogushi K, Niidome T, Aoyagi H, Yoshio K, Yonezawa K, Moss J, Hirayama T. 2003. Protein-tyrosine Phosphataseα,RPTPα,Is a Helicobacter pylori VacA Receptor. Journal of Biological Chemistry, 278(3):19183~19189
Yamaoka Y, Kudo T, Lu H, et al.2004.Role of interferonstimulated responsive element-like element in interleu- kin-8 promoter in Helicobacter pylori infection.Gastroenterology, 126(4): 1030~1043
Yamaoka Y, Kwon D H, Graham D Y. 2000. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proceedings of the National Academy of Sciences of the United States of America, 97(13):7533~7538
Yamasaki E, Wada A, Kumatori A, Nakagawa I, Funao J, Nakayama M, Hisatsume J, Kimura M, Moss J, Hirayama T. 2006. Helicobacter pylori vacuolating cytotoxin indeces activation of the proapototic proteins Bax and Bak,leading to cytochrome c release and cell death,independent of vacuolation. Journal of Biological Chemistry, 81(16):11250~11259
Ye D, Willhitr D C, Blanke S R.1999.Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating toxin.Journal of Biological Chemistry, 274(14):9277~9282
Zambon C F , Basso D, Navaglia F, Germano G, Gallo N, Milazzo M, Greco E, Fogar P, Mazza S, Di Mario F, Basso G, Rugge M, Plebani M. 2002. Helicobacter pylori virulence genes and host IL-1RN and IL-1βgenes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine, 18(5):242~251
Zamora M, Granell M, Mampel T, Vinas O. 2004. Adenine nucleotide translocase 3 (ANT3) overexpression induces apoptosis in cultured cells. FEBS Letters, 563(1):155~160
Zamzami N, Hirsch T, Dallaporta B, Petit P X, Kroemer G. 1997. Mitochondrial implication in accidental and programmed cell death:apoptosis and necrosis. Journal of Bioenergy Biomembrane, 29(2):185~193
Zamzami N, Susin S A, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G. 1996. Mitochondrial control of nuclear apoptosis. Journal of Experimental Medicine, 183(4): 1533~1544
Zanotti G, Papinutto E, Dundon W, Battistutta R, Seveso M, Del Giudice G, Rappuoli R, Montecucco C. 2002. Structure of the neutrophil-activationg protein from Helicobacter pylori. Journal of Molecular Biology, 323(1):125~130
Zeaiter Z, Cohen D, Musch A, Bagnoli F, Covacci A, Strin M. 2008. Analysis of detergent-resistant membranes of Helicobacter pylori infected gastric adenocarcinoma cells reveals a role for MARK2/Parlb in CagA-mediated disruption of cellular polarity. Cell Microbiology, 10(3):781~794
Zheng P Y, Jones N L.2003. Helicobacter pyori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO(coronin I) protein.Cell Microbiology, 5(1):25~40
Zoratti M, Szabo I. 1995. The mitochondrial permeability transition. Biochim Biophys Acta , 1241(2): 139~176